Early onset COPD

COPD_EARLY

chronic obstructive pulmonary disease: A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Pre-conditions: EVENT_AGE<65 Registry filters: Hospital discharge: ICD-10 — J44 Hospital discharge: ICD-9 — 4912 Hospital discharge: ICD-8 — 49104 Cause of death: ICD-10 — J44 Cause of death: ICD-9 — 4912 Cause of death: ICD-8 — 49104 2 out of 7 registries used, show all original rules.	10095
4. Check minimum number of events None	10095
5. Include endpoints None	10095
6. Filter based on genotype QC (FinnGen only)	9795

Control definitions (FinnGen only)

Control exclude: COPD_EARLYANDLATER

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J40-J47
Name in latin: Alii morbi obstructivi chronici pulmonum

NAME	COPD_EARLY
CONTROL_EXCLUDE	COPD_EARLYANDLATER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS	EVENT_AGE<65
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J44
HD_ICD_9	4912
HD_ICD_8	49104
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J44
COD_ICD_9	4912
COD_ICD_8	49104
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Early onset COPD based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Early onset COPD, excluding more controls

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	81002	25780	53894
Only index persons	60251	21696	38555
Unadjusted period prevalence (%)
Whole population	1.26	0.74	1.51
Only index persons	1.23	0.80	1.47
Median age at first event (years)
Whole population	57.10	56.55	57.32
Only index persons	56.50	56.17	56.69

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9795	3697	6098
Unadjusted period prevalence (%)	2.23	1.31	2.79
Median age at first event (years)	57.32	56.09	58.07

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10095: Matched controls
100950

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R06.2

ICD-10 Finland

Wheezing

4.8

321.0

766

1700

N05BA01

ATC

diazepam; systemic, rectal

2.9

318.8

1826

7232

R03AK08

ATC

formoterol and beclometasone; inhalant

4.7

317.9

775

1750

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

317.4

303

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.2

316.9

1409

4835

N05CD07

ATC

temazepam; oral

2.9

315.2

1693

6473

XG466

NOMESCO Finland

Sleep oxymetry

5.3

313.8

659

1311

R03BB07

ATC

umeclidinium bromide; inhalant

15.5

311.5

272

180

R04.2

ICD-10 Finland

Haemoptysis

5.0

309.6

704

1500

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

589.6

307.7

8458

877

R06.0

ICD-10 Finland

Dyspnoea

3.8

307.7

4305

16399

J01MA12

ATC

levofloxacin; systemic

2.7

307.7

2705

12091

R03AK03

ATC

[U] fenoterol and ipratropium bromide

17.0

307.7

2105

1541

J96.1

ICD-10 Finland

Chronic respiratory failure

29.1

307.7

1030

393

N05AA02

ATC

levomepromazine; systemic

4.9

307.7

800

1756

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

307.7

537

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

14.1

307.7

343

251

GD1AD

NOMESCO Finland

Thorax CT examination

4.0

307.7

1080

2933

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

307.7

605

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

5.3

307.7

2312

5351

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.1

307.7

1067

2271

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.6

307.7

1365

2337

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

22.3

307.7

393

183

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.0

307.7

1295

3566

R03DA04

ATC

theophylline; systemic, rectal

16.2

307.7

2013

1524

Z72.0

ICD-10 Finland

Tobacco use

8.2

307.7

677

877

J45

ICD-10 Finland

Asthma

4.1

307.7

1689

4749

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

13.0

307.7

1092

933

R03BA01

ATC

beclometasone; inhalant

4.3

307.7

2520

7239

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

43.2

307.7

1244

327

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.7

307.7

3034

10497

H02AB04

ATC

methylprednisolone; systemic

3.0

307.7

2099

8065

J45.0

ICD-10 Finland

Predominantly allergic asthma

5.2

307.7

1615

3593

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

202.6

307.7

3369

249

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

20.7

307.7

309

154

R03AK06

ATC

salmeterol and fluticasone; inhalant

10.2

307.7

4128

6395

H02AB07

ATC

prednisone; oral

3.9

307.7

2405

7517

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.1

307.7

1930

3791

R03AC18

ATC

indacaterol; inhalant

43.5

307.7

369

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

307.7

2709

10865

R03DC03

ATC

montelukast; oral

3.3

307.7

2372

8549

J43.9

ICD-10 Finland

Emphysema, unspecified

24.9

307.7

676

290

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

13.4

307.7

5884

9551

H02AB06

ATC

prednisolone; systemic

5.8

307.7

7544

34138

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.4

307.7

754

1491

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

12.7

307.7

655

549

J01AA02

ATC

doxycycline; systemic

3.0

307.7

8567

65473

R03AC02

ATC

salbutamol; inhalant

8.4

307.7

8389

37187

J45.8

ICD-10 Finland

Mixed asthma

9.3

307.7

841

982

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

30.2

307.7

1460

562

R03BB04

ATC

tiotropium bromide; inhalant

38.1

307.7

5523

3103

J46

ICD-10 Finland

Status asthmaticus

9.8

307.7

759

829

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.2

307.7

5772

37659

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

43.4

307.7

299

R03BB01

ATC

ipratropium bromide; inhalant

14.5

307.7

1387

1100

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.6

307.7

4678

15821

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

6.7

307.7

651

1033

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.7

307.7

1289

3811

C03CA01

ATC

furosemide; systemic

3.2

307.7

4391

19605

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

24.2

307.7

504

219

R03AK07

ATC

formoterol and budesonide; inhalant

4.4

307.7

3648

11504

J45.1

ICD-10 Finland

Nonallergic asthma

7.6

307.7

1897

2999

R95

ICPC

Chron obstructive pulmonary disease

54.1

307.7

1822

409

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

5.4

307.7

1933

4259

R02

ICPC

Shortness of breath/dyspnoea

4.3

307.7

2300

6503

J01MA14

ATC

moxifloxacin; systemic

4.3

307.7

1718

4620

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

60.4

307.7

242

J45.9

ICD-10 Finland

Asthma, unspecified

7.6

307.7

4484

9647

R03BA05

ATC

fluticasone; inhalant

4.3

307.7

3083

9430

R03AC13

ATC

formoterol; inhalant

7.9

307.7

1284

1838

J01FA06

ATC

roxithromycin; oral

2.4

307.7

4756

27460

R03AC03

ATC

terbutaline; inhalant

3.9

307.7

2239

6947

R96

ICPC

Asthma

4.6

307.7

1764

4441

R03AC12

ATC

salmeterol; inhalant

10.8

307.7

1371

1442

R03BA02

ATC

budesonide; inhalant

4.1

307.7

3007

9401

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

263.4

307.7

3644

216

I50.9

ICD-10 Finland

Heart failure, unspecified

3.1

307.7

1983

7348

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

310.9

307.7

2451

104

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.2

307.7

1492

5167

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

30.5

307.7

860

307

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

44.8

307.7

409

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.6

307.7

1002

2363

N07BA03

ATC

varenicline; oral

7.0

307.7

1191

1901

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

42.5

307.7

949

246

XG410

NOMESCO Finland

Flow-volume spirometry

6.7

307.7

945

1528

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

307.7

6029

35395

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

11.9

305.1

312

270

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

4.5

304.7

796

1898

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

303.0

2316

10578

348

Kela drug reimbursment

Roflumilast

2648.9

278.1

268

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

277.8

1064

3318

N06AB04

ATC

citalopram; systemic

2.4

277.2

2514

12352

R03BB02

ATC

oxitropium bromide; inhalant

20.2

276.8

212

107

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.5

276.0

558

1071

J96.0

ICD-10 Finland

Acute respiratory failure

9.6

271.0

323

348

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

7.5

258.1

376

518

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.3

257.7

539

1066

N05AH04

ATC

quetiapine; oral

2.5

254.4

2010

9244

R03DX07

ATC

roflumilast; oral

2355.7

248.7

240

I50.0

ICD-10 Finland

Congestive heart failure

3.3

247.9

1034

3392

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.2

247.8

528

1061

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.1

247.4

540

1108

R03AC19

ATC

olodaterol

31.5

243.2

158

N05CF01

ATC

zopiclone; oral

2.1

242.6

3662

21847

N02AX02

ATC

tramadol; systemic, rectal

2.0

238.9

4989

33326

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

237.6

2038

9696

SPAT1059

SPAT

Spirometry at the office

3.7

236.6

793

2258

N07BB01

ATC

disulfiram; oral

3.8

234.9

751

2070

J20

ICD-10 Finland

Acute bronchitis

2.8

226.4

1297

5078

R03BB06

ATC

glycopyrronium bromide; inhalant

28.0

225.5

152

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.0

224.8

681

1806

N05BA04

ATC

oxazepam; oral

2.1

223.3

2826

15702

J42

ICD-10 Finland

Unspecified chronic bronchitis

8.6

218.3

281

334

P17

ICPC

Tobacco abuse

7.9

214.8

297

385

Z2446

NOMESCO Finland

Social worker

3.3

214.0

851

2703

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

212.6

1366

5658

A06AD11

ATC

lactulose; oral

2.4

211.3

1816

8605

N05AF03

ATC

chlorprothixene; systemic

5.0

209.8

460

946

C07AB07

ATC

bisoprolol; oral

1.9

207.8

5424

38365

SPAT1254

SPAT

Administration of medicine

2.4

205.9

1694

7867

J47

ICD-10 Finland

Bronchiectasis

6.3

204.5

351

575

R03AK11

ATC

formoterol and fluticasone; inhalant

5.2

201.5

429

860

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.6

201.2

389

715

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

7.6

193.3

278

377

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.0

189.0

2726

15729

C03DA01

ATC

spironolactone; oral

2.4

188.4

1495

6812

G47.3

ICD-10 Finland

Sleep apnoea

2.0

188.4

2883

16978

A07AA02

ATC

nystatin; oral

3.2

187.6

788

2583

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.2

187.1

390

767

XG405

NOMESCO Finland

Education on PEF monitoring

6.7

186.8

300

459

J01FF01

ATC

clindamycin; systemic

1.9

186.6

3065

18480

K05.31

ICD-10 Finland

Periodontitis pronounced

2.4

185.5

1483

6777

N05AH03

ATC

olanzapine; systemic

3.2

184.8

782

2574

R03BA08

ATC

ciclesonide; inhalant

2.7

184.7

1073

4210

A01AB09

ATC

miconazole; local oral

2.8

184.2

1031

3968

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

9.1

177.5

218

244

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

34.0

174.9

111

WX892

NOMESCO Finland

Monitored bed care

2.7

172.4

1033

4111

N05BA02

ATC

chlordiazepoxide; systemic

4.4

170.5

438

1024

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.2

170.2

355

698

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.4

168.8

643

1982

J01DA01

ATC

[U] cefalexin

1.8

168.6

6254

47925

XG460

NOMESCO Finland

Short time oxymetry

6.2

166.3

286

469

WX722

NOMESCO Finland

PEEP

3.1

166.3

727

2436

N06AX11

ATC

mirtazapine; oral

1.8

164.5

3436

22190

R05CB01

ATC

acetylcysteine; inhalant, oral

6.4

164.5

274

435

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.1

164.4

352

708

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

163.8

3198

20223

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.4

162.9

418

976

N02AA05

ATC

oxycodone; systemic

2.0

161.7

2039

11131

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.1

160.1

725

2478

EBA00

NOMESCO Finland

Extraction of tooth

1.8

155.6

3664

24432

A46

ICD-10 Finland

Erysipelas

2.1

155.1

1774

9328

A02BC02

ATC

pantoprazole; systemic

1.8

154.8

6975

55867

J43.8

ICD-10 Finland

Other emphysema

22.0

153.1

113

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

152.9

1469

7215

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

151.7

2452

14537

N03AG01

ATC

valproic acid; systemic, rectal

2.9

151.4

755

2723

C01AA05

ATC

digoxin; systemic

2.6

149.4

939

3817

V03AA01, ,

ATC

4.9

149.3

338

713

N06AB03

ATC

fluoxetine; oral

2.2

146.0

1335

6417

P15

ICPC

Chronic alcohol abuse

3.8

145.3

465

1276

N03AX16

ATC

[U] pregabalin

1.9

143.6

2524

15331

TGC00

NOMESCO Finland

Bronchial lavation

4.0

143.4

417

1069

WX725

NOMESCO Finland

Noninvasive ventilation

2.9

143.3

731

2667

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

142.8

1387

6829

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

142.1

955

4006

R03BB05

ATC

aclidinium bromide; inhalant

23.4

141.8

102

A02BC01

ATC

omeprazole; systemic

1.8

141.0

2860

18135

R28

ICPC

Limited function/disability (R)

6.2

140.3

242

398

F10.24

ICD-10 Finland

Alcohol depence active use

5.3

140.2

289

562

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

139.2

1424

7151

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.8

138.9

318

677

N05AA01

ATC

chlorpromazine; systemic, rectal

5.9

138.5

253

440

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.5

138.5

504

1506

ZXD05

NOMESCO Finland

Urgent procedure

1.8

137.8

3054

19853

N06AX16

ATC

venlafaxine; oral

2.1

137.0

1415

7130

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

136.9

840

3369

Z3231

NOMESCO Finland

Registered nurse

1.8

135.9

2864

18333

N05AH02

ATC

clozapine; systemic

5.4

135.2

271

514

J37.0

ICD-10 Finland

Chronic laryngitis

3.6

134.9

468

1355

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

9.1

133.7

164

183

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

133.7

2760

17545

J96.9

ICD-10 Finland

Respiratory failure, unspecified

9.8

132.5

154

160

Z3226

NOMESCO Finland

Physiotherapist

1.9

132.5

1937

11048

R81

ICPC

Pneumonia

3.4

131.6

490

1485

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

131.6

1323

6589

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

130.7

817

3305

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.9

130.5

290

602

R60.0

ICD-10 Finland

Localized oedema

2.1

129.9

1362

6892

N05AB01

ATC

dixyrazine; systemic

5.7

129.5

246

444

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.1

129.3

565

1887

J43

ICD-10 Finland

Emphysema

36.6

128.6

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

4.4

128.5

327

758

N05BA06

ATC

lorazepam; systemic, sublingual

2.9

126.8

645

2346

J43.2

ICD-10 Finland

Centrilobular emphysema

15.0

125.4

111

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.0

125.1

371

964

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

5.4

125.0

250

473

E66.00

ICD-10 Finland

Metabolic syndrome

2.7

123.8

737

2908

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.7

123.1

400

1108

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.5

122.8

303

685

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

122.8

2023

11960

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

122.2

1469

7808

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.6

121.9

235

430

R05

ICPC

Cough

1.8

121.5

2304

14219

A02BA02

ATC

ranitidine; systemic

1.8

119.9

2057

12306

A28

ICPC

Limited function/disability NOS

1.9

119.5

1705

9612

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

8.4

119.2

156

189

N05AD01

ATC

haloperidol; systemic

3.4

119.1

442

1336

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.4

118.8

452

1388

R05FB02

ATC

cough suppressants and expectorants; systemic

1.7

118.6

3710

26234

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

6.7

118.3

188

284

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

117.8

3388

23433

J01FA09

ATC

clarithromycin; systemic

1.7

115.8

3022

20355

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

16.7

114.9

N05AB03

ATC

perphenazine; systemic, rectal

3.3

114.9

457

1442

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

114.7

2995

20167

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

114.7

684

2699

N06AA12

ATC

doxepin; systemic

2.7

114.5

634

2409

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.3

113.9

194

315

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

27.7

113.7

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

6.9

112.7

174

255

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

8.1

111.9

150

187

N04AA02

ATC

biperiden; systemic

4.3

111.9

294

698

N06AX12

ATC

bupropion; oral

2.7

110.3

640

2490

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.6

110.0

661

2617

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

8.4

109.9

143

172

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

108.9

1253

6537

R03DC01

ATC

zafirlukast; oral

4.9

108.9

243

506

J01CA04

ATC

amoxicillin; systemic

1.7

108.5

7774

66744

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.9

108.0

240

498

A01AB04

ATC

amphotericin B; local oral

2.9

107.9

546

1977

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

107.5

2026

12420

WX721

NOMESCO Finland

Oxygen concentrator therapy

22.1

107.3

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

5.4

107.2

212

397

J98.1

ICD-10 Finland

Pulmonary collapse

8.8

107.1

135

156

M05BA04

ATC

alendronic acid; oral

2.4

107.1

814

3596

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.7

106.8

346

956

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

106.4

1732

10152

N05AC02

ATC

thioridazine; oral

4.3

106.2

282

675

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.2

106.1

426

1351

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

105.8

3088

21309

P01AB01

ATC

metronidazole; oral, rectal

1.6

104.5

3714

26878

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.1

104.4

181

299

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.3

104.4

211

403

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

6.7

104.0

165

249

A10BA02

ATC

metformin; oral

1.6

104.0

3076

21280

WX730

NOMESCO Finland

Conventional respirator

4.5

103.4

253

568

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.9

102.7

305

793

N05AF05

ATC

zuclopenthixol; systemic

5.9

102.4

184

315

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

102.3

1437

8023

A02BC03

ATC

lansoprazole; oral

1.6

102.2

2889

19740

C01DA14

ATC

isosorbide mononitrate; oral

1.8

101.7

1651

9657

A98

ICPC

Health maint/preventive medicine

0.6

101.4

8250

89778

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

99.5

2390

15635

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.8

99.4

306

816

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

99.2

2605

17443

N05AX12

ATC

aripiprazole; systemic

3.3

99.2

378

1161

N05AX08

ATC

risperidone; systemic

2.3

99.0

836

3860

K08.3

ICD-10 Finland

Retained dental root

2.2

98.8

907

4333

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

98.6

1071

5459

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

98.2

416

1362

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

97.8

1306

7163

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.8

97.3

178

310

SPAT1058

SPAT

PEF monitoring instruction

2.2

97.2

861

4053

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

97.1

782

3537

N06AX03

ATC

mianserin; oral

2.7

96.6

561

2181

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.8

96.4

219

463

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

94.9

2978

20806

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.6

94.7

180

325

N05BE01

ATC

buspirone; oral

3.2

94.6

378

1195

N06AA09

ATC

amitriptyline; systemic

2.1

94.6

1011

5120

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

8.7

94.5

120

140

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

94.4

1391

7875

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.0

94.3

440

1523

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

94.1

2862

19837

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

5.2

94.0

196

385

J01FA15

ATC

telithromycin; oral

2.0

93.8

1056

5450

R4110

NOMESCO Finland

Physiotherapy

1.6

93.6

2745

18852

S97

ICPC

Chronic ulcer skin

2.4

93.1

710

3136

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

93.0

707

3118

R06AE07

ATC

cetirizine; oral

1.6

92.6

3883

28970

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

7.8

92.4

128

166

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

5.0

92.4

199

402

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

91.4

2422

16201

F17.3

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, withdrawal state

22.9

90.9

XQ800

NOMESCO Finland

Prick test

2.4

89.3

685

3032

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

89.0

2487

16839

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

10.9

88.6

SPAT1263

SPAT

Sampling

1.5

88.3

3828

28684

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

88.2

1555

9290

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.5

88.1

217

490

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

88.0

766

3575

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

3.8

87.4

274

740

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.1

87.4

186

372

T90

ICPC

Diabetes non-insulin dependent

1.6

87.0

2578

17691

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.9

86.8

156

267

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.1

85.2

182

365

SPE90

NOMESCO Finland

Other partial denture

3.5

85.2

306

905

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

84.9

783

3739

N06AB06

ATC

sertraline; oral

2.0

84.4

1008

5303

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

83.6

2220

14805

GDG10

NOMESCO Finland

Bilateral transplantation of lung

24.7

83.6

RS221, ,

NOMESCO Finland

4.6

83.4

200

442

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.7

83.4

157

281

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

83.3

508

2021

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.1

83.2

353

1156

1240

FHL

Bronchoscopy

5.2

83.2

173

339

N06AB10

ATC

escitalopram; oral

1.7

82.4

1716

10733

R29

ICPC

Respiratory symptom/complaint other

2.3

82.3

689

3163

N03AX12

ATC

[U] gabapentin; oral

1.7

82.2

1618

9961

E66.8

ICD-10 Finland

Other obesity

2.5

82.1

554

2312

R78

ICPC

Acute bronchitis/bronchiolitis

3.6

81.7

276

784

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

6.5

81.3

132

204

J01DA09

ATC

[U] cefadroxil

1.6

81.3

2468

16989

49300

ICD-8 Finland

Asthma, bronchiale

3.4

81.2

301

908

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

81.0

715

3353

B01AC04

ATC

clopidogrel; oral

1.7

80.8

1769

11209

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

5.3

80.2

163

313

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.1

80.0

221

545

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

79.4

2600

18199

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

79.3

2675

18854

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

5.0

79.1

170

343

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

10.0

79.0

SPAT1060

SPAT

Administration of oxygen

10.1

78.7

A41.9

ICD-10 Finland

Sepsis, unspecified

2.8

78.7

423

1579

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

9.0

78.7

109

J01DA06

ATC

[U] cefuroxime

1.8

78.1

1389

8296

Z2221

NOMESCO Finland

Medical doctor

1.6

77.8

2484

17272

F61.0

ICD-10 Finland

Mixed personality disorders

4.3

77.2

202

478

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

76.9

567

2463

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

76.8

4291

33591

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.5

76.8

126

197

A02BA04

ATC

nizatidine; systemic

2.1

76.8

809

4063

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

7.5

76.5

109

146

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

4.0

76.1

223

574

P72

ICPC

Schizophrenia

3.8

76.0

238

642

P99

ICPC

Psychological disorders other

3.3

75.8

292

902

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

75.4

679

3209

GDC00

NOMESCO Finland

Lobectomy of lung

7.2

75.1

112

158

N06AX21

ATC

duloxetine; oral

1.9

75.0

1087

6092

Z94.2

ICD-10 Finland

Lung transplant status

14.7

75.0

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

74.9

450

1776

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

5.0

74.5

162

330

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

74.5

474

1924

SPAT1240

SPAT

Therapeutic discussion

2.0

74.0

834

4290

R79

ICPC

Chronic bronchitis

14.9

73.3

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.5

73.2

260

763

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

73.0

2526

17848

S10

ICPC

Boil/carbuncle

2.3

72.9

613

2816

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

72.3

1034

5768

J01DB01

ATC

cefalexin; oral

1.6

72.1

7945

70806

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

4.9

72.1

159

328

AN1

Coronary angiography

1.8

72.0

1200

7019

Z51.5

ICD-10 Finland

Palliative care

2.0

71.9

829

4299

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

71.5

1224

7216

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

6.2

71.4

123

202

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.2

71.0

191

462

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

12.9

70.7

AA1AD

NOMESCO Finland

CT of head and brain

1.5

70.6

2645

18992

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

5.7

70.5

132

235

N05BA12

ATC

alprazolam; oral

1.9

70.5

970

5342

I50.1

ICD-10 Finland

Left ventricular failure

2.3

70.3

554

2476

R03DA05

ATC

aminophylline; systemic, rectal

6.4

70.1

116

183

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

4.8

70.1

158

332

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

70.0

2678

19306

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

5.3

70.0

140

265

L28

ICPC

Limited function/disability (L)

1.7

69.7

1617

10363

B18.2

ICD-10 Finland

Chronic viral hepatitis C

5.2

69.7

143

277

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

7.3

69.3

101

139

N03AF01

ATC

carbamazepine; oral, rectal

2.3

68.6

548

2462

S22.3

ICD-10 Finland

Fracture of rib

2.0

68.3

771

3965

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

68.2

487

2084

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.3

68.1

265

824

E87.6

ICD-10 Finland

Hypokalaemia

2.7

68.0

365

1361

N05AN01

ATC

lithium; oral

3.2

67.9

272

861

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

6.0

67.9

119

199

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

67.8

923

5062

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

6.4

67.5

111

174

P29

ICPC

Psychological sympt/compl other

2.3

67.4

520

2302

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.4

67.3

250

755

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

8.1

67.3

112

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

67.2

1142

6711

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.9

67.1

149

309

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

67.1

3760

29216

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

67.1

2569

18497

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

66.9

362

1355

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

66.8

559

2561

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

19.4

66.7

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

13.2

66.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

66.4

3804

29667

B01AA03

ATC

warfarin; systemic

1.6

66.2

1898

12803

J15.8

ICD-10 Finland

Other bacterial pneumonia

5.7

66.0

123

218

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

6.6

65.6

106

163

N02AA01

ATC

morphine; systemic, rectal

3.5

65.6

228

660

A03

ICPC

Fever

1.7

65.6

1340

8293

N03AX09

ATC

lamotrigine; oral

2.5

65.5

427

1752

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.1

65.4

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

5.4

65.3

128

238

Z72.1

ICD-10 Finland

Alcohol use

4.0

65.0

186

471

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

64.9

581

2735

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

64.4

2321

16470

E000001, ,

ATC

1.6

64.4

1733

11506

R04

ICPC

Breathing problem other

2.5

64.1

408

1655

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

63.6

1361

8522

R03AC04

ATC

fenoterol; inhalant

7.7

63.5

117

SPAT1262

SPAT

Handing over of treatment supplies

1.6

63.4

1788

11999

F34.1

ICD-10 Finland

Dysthymia

2.7

63.2

338

1258

A01

ICPC

Pain general/multiple sites

1.9

63.0

839

4563

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

5.7

62.3

115

202

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

62.2

511

2322

WX882

NOMESCO Finland

High dependency care

2.8

62.2

327

1206

ZXE00

NOMESCO Finland

One hour or less

1.4

62.1

3475

26886

GX1K5

NOMESCO Finland

Diffusion capacity

6.5

61.5

100

155

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.7

60.9

140

299

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

6.3

60.9

102

163

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.0

60.8

177

454

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.6

60.6

145

320

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

60.6

1146

6933

OAB43, ,

SPAT

0.5

60.4

733

13071

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.0

60.2

174

444

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

60.1

417

1760

P16

ICPC

Acute alcohol abuse

3.5

59.8

210

612

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.1

59.6

589

2881

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

59.3

673

3464

P03

ICPC

Feeling depressed

2.0

59.2

679

3507

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.5

58.8

203

585

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

58.8

1739

11780

R05CB02

ATC

bromhexine; systemic

3.7

58.6

185

502

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

10.6

58.5

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

58.4

675

3496

E0000UV, ,

ATC

1.4

58.2

3584

28131

M54.5

ICD-10 Finland

Low back pain

1.4

58.2

3093

23634

A10AE04

ATC

insulin glargine; parenteral

1.8

58.1

980

5734

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

58.1

462

2071

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

57.7

1060

6355

130

Kela drug reimbursment

Malignant tumour

1.8

57.6

953

5542

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

5.9

57.5

103

176

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

9.4

57.1

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.7

57.0

325

1249

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

56.9

704

3732

RK320, ,

NOMESCO Finland

4.9

56.9

126

261

R03CC02

ATC

salbutamol; systemic

2.7

56.8

313

1183

ZX120

NOMESCO Finland

Intravenous

1.8

56.5

906

5219

J41.0

ICD-10 Finland

Simple chronic bronchitis

5.7

56.4

105

186

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.6

56.3

185

516

C08DA01

ATC

verapamil; systemic

2.4

55.8

406

1750

J01FA10

ATC

azithromycin; systemic

1.4

55.6

4904

40831

SPD00

NOMESCO Finland

Mucosa borne complete denture

4.1

55.6

155

385

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

55.5

1506

9983

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

6.5

55.2

140

A02BC05

ATC

esomeprazole; systemic

1.4

54.9

3752

29906

WX872

NOMESCO Finland

Intensive care

2.1

54.8

582

2922

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

54.7

3526

27815

A04

ICPC

Weakness/tiredness general

1.7

54.1

1152

7184

RS220, ,

NOMESCO Finland

4.0

54.0

154

389

30041

ICD-8 Finland

Neuroses, Depressiva

3.8

54.0

167

447

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

5.9

53.9

163

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

5.2

53.9

111

216

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

53.7

454

2086

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

4.0

53.7

152

382

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

13.1

53.6

WW200

NOMESCO Finland

Immunization

2.7

53.6

302

1154

P01

ICPC

Feeling anxious/nervous/tense

1.9

53.5

708

3836

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

53.4

1021

6183

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.5

53.4

349

1433

W19

ICD-10 Finland

Unspecified fall

1.8

53.4

896

5228

R11

ICD-10 Finland

Nausea and vomiting

1.9

53.4

702

3797

A08

ICPC

Swelling

2.2

53.3

477

2244

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

4.6

52.7

124

270

SPAT1255

SPAT

Intravenous administration of medicine

1.9

52.7

677

3632

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

7.9

52.7

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

52.6

441

2020

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

52.4

2462

32110

P76

ICPC

Depressive disorder

2.1

52.4

490

2345

I25.2

ICD-10 Finland

Old myocardial infarction

1.9

52.3

707

3857

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.5

52.3

350

1453

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.9

52.3

114

233

M04AA01

ATC

allopurinol; systemic

1.6

52.3

1374

9029

N05AD03

ATC

melperone; systemic

3.7

52.1

165

449

EBA30

NOMESCO Finland

Extraction of root of tooth

2.0

52.1

607

3150

F17.22

ICD-10 Finland

Addiction-related addiction currently uses controlled substitution treatment

9.6

52.1

SPAT1057

SPAT

Peak expiratory flow measurement

3.0

51.8

237

811

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

51.7

1016

6196

R50.9

ICD-10 Finland

Fever, unspecified

1.6

51.7

1345

8814

A10AB05

ATC

insulin aspart; parenteral

1.9

51.6

749

4180

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

3.1

51.5

215

698

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

4.8

51.4

117

248

C08DB01

ATC

diltiazem; oral

2.1

51.3

494

2390

R05CB03

ATC

carbocisteine; oral

3.0

51.2

229

773

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

50.6

1814

12769

J98.2

ICD-10 Finland

Interstitial emphysema

21.2

50.6

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

5.6

50.5

170

R74

ICPC

Upper respiratory infection acute

1.5

50.5

2286

16859

R53

ICD-10 Finland

Malaise and fatigue

1.5

50.4

1920

13686

30180

ICD-8 Finland

Personality disorders, Immatura

5.7

50.4

167

J86.9

ICD-10 Finland

Pyothorax without fistula

4.4

50.3

128

297

N06AA06

ATC

trimipramine; systemic

2.8

50.2

257

935

J43.1

ICD-10 Finland

Panlobular emphysema

71.8

50.0

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

50.0

1810

12763

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

49.8

1283

8382

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.2

49.8

133

320

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

5.0

49.8

107

216

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

6.4

49.7

129

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

5.6

49.6

166

ZY010

NOMESCO Finland

Hospital outpatient

2.2

49.4

409

1863

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

49.2

463

2220

N05AF01

ATC

flupentixol; systemic

3.4

48.9

181

546

N05CD02

ATC

nitrazepam; oral

3.3

48.8

190

591

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

8.4

48.8

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

48.8

475

2307

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

48.5

384

1717

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.5

48.5

307

1242

N03AE01

ATC

clonazepam; systemic

2.0

48.5

547

2806

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

14.3

48.4

PEN23

NOMESCO Finland

Plastic repair of femoral artery

4.4

48.4

123

285

R03CC03

ATC

terbutaline; systemic

3.8

48.3

150

403

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.6

48.1

115

254

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

8.0

48.1

N06AB05

ATC

paroxetine; oral

2.0

48.1

536

2738

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.2

48.0

190

597

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

48.0

546

2808

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

48.0

445

2122

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.2

48.0

438

2076

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

48.0

483

2377

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

47.9

893

5364

Z08

ICPC

Social welfare problem

3.7

47.7

149

402

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

9.5

47.7

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

47.6

780

4514

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

47.5

783

4540

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

47.3

265

1010

RK110, ,

NOMESCO Finland

5.0

47.3

101

203

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.2

47.1

187

589

N05BB01

ATC

hydroxyzine; systemic

2.0

47.1

528

2702

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.3

47.1

356

1561

A02BA03

ATC

famotidine; systemic

2.3

47.0

378

1701

JN4BD

NOMESCO Finland

Extensive body CT

1.7

46.9

1026

6430

PD3AT

NOMESCO Finland

Pelvic artery PTA

5.3

46.8

179

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

46.7

609

3282

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.9

46.6

225

793

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

46.6

287

1146

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

5.2

46.6

187

C09AA05

ATC

ramipril; oral

1.4

46.5

2421

18280

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

4.9

46.5

101

206

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

5.3

46.1

174

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.8

46.0

241

887

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

46.0

875

5284

SPAT1234

SPAT

Support of social functional capacity

2.1

45.9

453

2212

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

45.8

349

1535

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.8

45.6

144

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

45.4

256

979

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

5.2

45.3

177

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

45.2

1264

8408

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

5.9

45.1

139

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

44.9

3186

25330

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

44.8

584

3145

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.5

44.7

153

439

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.8

44.6

136

361

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

8.9

44.5

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

44.4

1869

13547

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

44.4

612

3357

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

44.3

554

2944

E86

ICD-10 Finland

Volume depletion

2.6

44.2

252

969

XG420

NOMESCO Finland

Time-volume spirometry

13.7

44.2

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

4.5

44.1

106

235

SPAT1301

SPAT

No procedures

1.4

44.1

2683

20782

OAA67, ,

SPAT

0.5

43.9

323

6871

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.5

43.7

106

237

F20.0

ICD-10 Finland

Paranoid schizophrenia

4.9

43.6

198

A12BA01

ATC

potassium chloride; oral

2.2

43.6

372

1716

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

43.5

534

2820

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

43.4

1175

7753

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

43.4

1519

10607

RS230, ,

NOMESCO Finland

5.7

43.3

141

N02AC04

ATC

dextropropoxyphene; oral

2.2

43.3

366

1682

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.6

43.3

254

991

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

6.9

43.1

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

43.0

605

3340

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

4.9

42.9

193

F20.5

ICD-10 Finland

Residual schizophrenia

5.1

42.9

178

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

42.9

541

2882

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

5.2

42.8

171

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

42.7

561

3030

T74.1

ICD-10 Finland

Physical abuse

3.3

42.7

159

482

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

16.4

42.7

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.1

42.6

181

594

R51.80

ICD-10 Finland

Headache

1.6

42.4

1161

7677

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

4.1

42.3

116

285

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

42.2

569

3098

SPAT1104

SPAT

Monitoring of emergency patient

1.9

42.2

602

3338

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

3.0

42.1

189

640

SPAT1265

SPAT

Breathalyser

4.0

42.1

118

295

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

5.7

42.0

138

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

42.0

1145

7563

M79.6

ICD-10 Finland

Pain in limb

1.4

41.9

3552

28951

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.4

41.9

283

1180

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

4.4

41.9

105

241

F17.1

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, harmful use

12.0

41.9

J01FA01

ATC

erythromycin; systemic

1.6

41.8

1016

6529

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.0

41.7

191

654

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.9

41.7

195

676

A01AB10

ATC

natamycin; local oral

2.5

41.6

255

1016

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

5.4

41.6

150

E000003, ,

ATC

2.1

41.6

386

1841

J01DA08

ATC

[U] cefaclor

1.7

41.5

744

4413

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.3

41.5

108

255

K07

ICPC

Swollen ankles/oedema

2.1

41.4

408

1991

SPD01

NOMESCO Finland

Mucosa-supported complete denture

3.7

41.3

129

348

N06AB08

ATC

fluvoxamine; oral

2.5

41.3

269

1103

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.9

41.3

199

701

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

41.3

434

2169

R84

ICPC

Malignant neoplasm bronchus/lung

6.0

41.3

120

N02BF02

ATC

pregabalin; oral

1.9

41.2

520

2770

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

5.9

41.1

124

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

41.0

3367

27290

I50

ICD-10 Finland

Heart failure

2.5

40.9

273

1132

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.9

40.9

122

319

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

3.0

40.9

179

598

L17

ICPC

Foot/toe symptom/complaint

1.4

40.8

2444

18833

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

15.1

40.8

S76

ICPC

Skin infection other

1.9

40.8

499

2631

UJD02

NOMESCO Finland

Gastroscopy

2.0

40.8

452

2303

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

4.4

40.7

102

234

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

7.6

40.7

4289X

ICD-9 Finland

Heart failure, unspecified

6.7

40.6

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

40.6

328

1479

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

40.6

222

836

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

40.6

793

4817

K92.0

ICD-10 Finland

Haematemesis

2.5

40.5

256

1035

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

40.3

2458

18994

WX002

NOMESCO Finland

Sedation and analgesia

1.5

40.3

1737

12623

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.1

40.0

164

527

K70.1

ICD-10 Finland

Alcoholic hepatitis

4.4

40.0

225

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

40.0

945

6029

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

40.0

1391

9687

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

39.9

364

1724

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

13.8

39.9

RK250, ,

NOMESCO Finland

5.2

39.7

160

N06AA10

ATC

nortriptyline; systemic

2.8

39.7

206

755

UJF32

NOMESCO Finland

Coloscopy

1.4

39.6

2407

18578

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.9

39.4

554

3056

J02AC01

ATC

fluconazole; systemic

1.4

39.4

2883

22924

PE1AT

NOMESCO Finland

Femoral artery PTA

3.4

39.4

141

417

-50

ICPC

Medication/prescr/renewal

2.1

39.3

380

1841

DQA10

NOMESCO Finland

Biopsy of larynx

4.6

39.3

204

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

12.2

39.2

RS222, ,

NOMESCO Finland

3.6

39.2

129

361

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.1

39.2

109

271

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

5.4

39.1

144

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

39.1

1101

7320

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.4

39.1

140

414

L30.3

ICD-10 Finland

Infective dermatitis

2.2

39.0

333

1536

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

39.0

1883

13964

N05AA03

ATC

promazine; systemic

9.4

38.8

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

6.4

38.7

101

L57.0

ICD-10 Finland

Actinic keratosis

0.5

38.6

307

6362

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

38.6

431

2201

K29.2

ICD-10 Finland

Alcoholic gastritis

6.6

38.6

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.6

38.6

128

360

SPA47

NOMESCO Finland

Precision impression for denture

2.4

38.6

267

1126

D07AA02

ATC

hydrocortisone; topical

1.6

38.4

1072

7111

ZY000

NOMESCO Finland

Hospital inpatient

3.9

38.2

114

298

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.4

38.1

274

1175

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

6.9

38.1

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.7

38.0

213

812

GX2C5

NOMESCO Finland

Short-lasting oximetry

5.4

37.9

141

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

37.9

705

4224

SPAT1260

SPAT

Consultation of another employee

1.5

37.9

1496

10677

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

6.4

37.8

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

6.4

37.8

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.7

37.8

119

323

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.5

37.8

247

1015

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

9.1

37.7

JN4AD

NOMESCO Finland

Body CT examination

1.6

37.7

991

6483

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

37.6

3737

31035

N06AX05

ATC

trazodone; oral

2.6

37.5

228

905

R24

ICPC

Haemoptysis

4.6

37.4

192

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.7

37.3

208

791

D07AC01

ATC

betamethasone; topical

1.3

37.2

3196

25982

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

6.9

37.2

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.8

37.2

184

658

XF402

NOMESCO Finland

ECG with work load test

1.6

37.1

1015

6700

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

37.1

1498

10734

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

37.0

400

2020

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

37.0

3164

25704

I20.09

ICD-10 Finland

Unstable angina

1.8

36.9

555

3125

T82

ICPC

Obesity

2.2

36.9

329

1544

N05AL01

ATC

sulpiride; systemic

3.1

36.9

156

511

PD3BT

NOMESCO Finland

Pelvic artery extensive PTA

8.3

36.8

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.7

36.8

193

712

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

5.5

36.6

131

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

8.7

36.6

J01MA02

ATC

ciprofloxacin; systemic

1.3

36.6

3595

29778

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

36.5

529

2946

R03

ICPC

Wheezing

3.5

36.5

123

350

A10AC01

ATC

insulin (human); parenteral

1.7

36.4

659

3917

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

3.9

36.3

106

273

X57

ICD-10 Finland

Unspecified privation

2.5

36.3

224

896

R07.3

ICD-10 Finland

Other chest pain

1.6

36.3

884

5677

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.3

36.2

136

415

K59.0

ICD-10 Finland

Constipation

1.9

36.1

480

2600

F32

ICD-10 Finland

Depressive episode

2.1

36.1

374

1859

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

36.1

627

3685

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

3.5

36.0

124

358

SPE01

NOMESCO Finland

Mucosa-supported partial denture

2.5

35.9

219

871

R10.0

ICD-10 Finland

Acute abdomen

2.3

35.9

286

1283

C10AA01

ATC

simvastatin; oral

1.3

35.8

4020

33884

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.2

35.7

300

1376

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

35.6

1539

11161

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

35.6

382

1923

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.5

35.4

227

925

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

2.1

35.4

336

1617

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

35.3

322

1526

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

35.2

306

1422

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

35.2

345

1680

L82

ICD-10 Finland

Seborrhoeic keratosis

0.6

35.0

782

12026

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

34.9

331

1592

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

4.5

34.9

187

SPF30

NOMESCO Finland

Relining of denture

2.7

34.8

183

676

L03

ICPC

Low back symptom/complaint

1.4

34.7

2192

16966

F1246, ,

NOMESCO Finland

9.8

34.7

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

6.8

34.7

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.9

34.6

153

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.6

34.6

194

741

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.3

34.4

131

403

F20

ICD-10 Finland

Schizophrenia

4.5

34.2

186

R52.0

ICD-10 Finland

Acute pain

2.3

34.1

275

1239

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

34.0

402

2094

K85

ICD-10 Finland

Acute pancreatitis

2.7

34.0

181

673

R01AD09

ATC

mometasone; nasal

1.3

34.0

3694

30936

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

33.8

3297

27200

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

33.8

732

4563

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

33.6

163

577

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

33.6

231

972

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

33.6

6286

56477

RS224, ,

NOMESCO Finland

6.1

33.5

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

33.4

5959

53182

P28

ICPC

Limited function/disability (P)

4.2

33.3

215

GX1C5, ,

SPAT

4.7

33.3

166

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

6.4

33.2

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

7.9

33.2

WZC30

NOMESCO Finland

Teaching

1.4

33.1

1430

10361

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

33.0

725

4535

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

4.0

32.9

234

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.3

32.8

126

SPAT1229

SPAT

Assessment of need for aid

1.7

32.8

649

3952

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

5.2

32.5

127

K12.2

ICD-10 Finland

Cellulitis and abscess of mouth

3.3

32.4

120

363

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

6.0

32.4

I73.9

ICD-10 Finland

Peripheral vascular disease, unspecified

3.7

32.3

104

287

B37.0

ICD-10 Finland

Candidal stomatitis

3.5

32.3

112

325

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

32.2

262

1185

J93.8

ICD-10 Finland

Other pneumothorax

5.1

32.2

132

F61

ICD-10 Finland

Mixed and other personality disorders

5.5

32.1

114

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

9.1

32.1

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

6.2

32.1

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

6.2

32.1

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

32.1

184

711

SPAT1251

SPAT

Organisation of medication

2.1

31.9

292

1385

D11

ICPC

Diarrhoea

1.6

31.9

811

5256

SBA00

NOMESCO Finland

Microbiological examinations

2.3

31.8

233

1009

N06AG02

ATC

moclobemide; oral

1.9

31.8

384

2016

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.0

31.7

142

481

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

31.7

523

3028

R01

ICPC

Pain respiratory system

2.9

31.6

151

530

P74

ICPC

Anxiety disorder/anxiety state

2.2

31.6

261

1188

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

31.6

1894

14509

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

31.5

1660

21681

L01CA04

ATC

vinorelbine; systemic

3.7

31.5

101

278

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

31.5

1071

7400

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.8

31.5

260

V03AA02, ,

ATC

7.8

31.5

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

31.3

316

1556

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

6.9

31.3

49099

ICD-8 Finland

Bronchitis, unspecified

3.2

31.3

124

391

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

5.9

31.2

TGD00

NOMESCO Finland

Needle biopsy of lung

4.6

31.2

159

V03AB30, ,

ATC

3.6

31.1

103

290

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

3.9

31.0

231

A10BB12

ATC

glimepiride; oral

1.7

30.9

630

3865

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

30.7

220

943

SPAT1284

SPAT

Extensive health certificate

2.3

30.7

233

1025

R52.2

ICD-10 Finland

Other chronic pain

2.1

30.6

310

1529

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.4

30.6

110

327

GBB00

NOMESCO Finland

Tracheostomy

3.0

30.5

134

449

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.3

30.5

113

342

R13

ICD-10 Finland

Dysphagia

1.7

30.5

602

3661

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

9.1

30.3

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.9

30.3

142

494

M48.0

ICD-10 Finland

Spinal stenosis

1.5

30.2

1086

7583

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

30.2

619

3801

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.8

30.2

491

2829

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

30.2

1828

14016

J01CF05

ATC

flucloxacillin; systemic

1.8

30.2

511

2980

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

30.1

339

1736

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

6.6

30.1

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

8.7

30.1

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

30.0

309

1533

N02BF01

ATC

gabapentin; oral

1.6

30.0

684

4317

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.4

29.9

201

837

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

29.9

1928

14923

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.1

29.9

202

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

5.7

29.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

29.8

1079

7546

SPAT1310

SPAT

Counselling related to known health issue

1.3

29.7

2579

20859

F60.2

ICD-10 Finland

Dissocial personality disorder

7.3

29.6

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

29.5

583

3545

UDQ22

NOMESCO Finland

Microlaryngoscopy

3.5

29.5

281

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

4.2

29.5

187

N02BE01

ATC

paracetamol; systemic, rectal

1.4

29.4

8349

78522

SAA04

NOMESCO Finland

Special examination of mouth

1.8

29.4

424

2357

M05BA07

ATC

risedronic acid; oral

2.4

29.4

206

875

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

29.3

366

1943

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

6.1

29.2

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

29.2

395

2153

F31

ICD-10 Finland

Bipolar affective disorder

3.3

29.1

109

332

4910A

ICD-9 Finland

Chronic bronchitis, Simple chronic bronchitis

10.0

29.1

PDQ20

NOMESCO Finland

Insertion of endovascular graft into common iliac artery

4.7

29.1

140

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

29.1

529

3147

29999

ICD-8 Finland

Unspecified psychosis

5.0

29.0

125

G44.2

ICD-10 Finland

Tension-type headache

1.5

28.9

976

6726

J93.9

ICD-10 Finland

Pneumothorax, unspecified

4.8

28.9

133

30188

ICD-8 Finland

Personality disorders, Alia definita

4.7

28.9

141

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

28.9

432

2429

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.7

28.8

159

603

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

28.7

144

520

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

28.7

352

1858

51899

ICD-8 Finland

Bronchiectasis

8.1

28.6

R07.1

ICD-10 Finland

Chest pain on breathing

2.8

28.6

144

521

R39

ICPC

Respiratory, Physical function test

4.3

28.5

175

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

2.8

28.5

141

505

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

28.5

387

2111

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

28.4

3943

33829

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

28.3

435

2465

N05CF02

ATC

zolpidem; oral

1.4

28.3

1380

10194

R52.9

ICD-10 Finland

Pain, unspecified

1.6

28.3

785

5188

N06AA04

ATC

clomipramine; systemic

2.6

28.2

159

609

F2682, ,

NOMESCO Finland

9.2

28.2

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

8.2

28.2

C08CA01

ATC

amlodipine; oral

1.3

28.2

3513

29741

D07AB08

ATC

desonide; topical

1.5

28.2

847

5697

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

5.9

28.2

ZX108

NOMESCO Finland

Inhalation

3.7

28.1

243

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

28.1

615

3840

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

28.1

1086

7688

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

6.0

28.0

Y3409

ICD-8 Finland

Follow-up examination of illness, accident or surgery, Treated inactive pulmonary tuberculosis

10.4

28.0

B37.08

ICD-10 Finland

Other candidal stomatitis

3.6

28.0

258

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.1

28.0

114

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

27.9

370

2002

A10BJ02

ATC

liraglutide; parenteral

2.1

27.9

267

1289

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

4.6

27.9

141

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

27.9

354

1889

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.1

27.9

265

1277

29599

ICD-8 Finland

Schizophrenia, Unspecified type

4.3

27.8

170

ECB00

NOMESCO Finland

Suture of gingiva

1.9

27.8

332

1736

F41.00

ICD-10 Finland

Moderate panic disorder

3.0

27.7

119

394

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

3.9

27.6

210

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

6.9

27.5

A02BX02

ATC

sucralfate; oral

1.9

27.5

345

1835

TK800

NOMESCO Finland

Hemodialysis

2.3

27.4

219

985

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.7

27.3

483

2850

SPAT1216

SPAT

Assessment of functional ability

1.4

27.3

1232

8972

GX1E5, ,

SPAT

3.2

27.3

108

341

A99

ICPC

Disease/condition unspecnature/site

1.6

27.2

746

4914

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.2

27.2

221

1000

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

27.2

553

3388

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

27.2

124

425

A10BH01

ATC

sitagliptin; oral

1.5

27.2

882

6027

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.4

27.2

183

764

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

7.6

27.1

-69

ICPC

Other reason for encounter NEC

2.0

27.1

309

1590

SPAT1227

SPAT

Substance abuse rehabilitation

4.0

27.1

195

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

7.2

27.1

R05DB05

ATC

pentoxyverine; oral, rectal

2.0

27.0

308

1585

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

27.0

263

1279

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

26.9

1243

9091

7863A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Haemoptysis

5.6

26.9

C07AA05

ATC

propranolol; systemic

1.4

26.8

1510

11418

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

6.5

26.8

S06.0

ICD-10 Finland

Concussion

1.5

26.7

813

5480

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

4.0

26.7

184

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.6

26.6

243

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

26.6

161

639

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.8

26.6

397

2230

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

8.5

26.6

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.0

26.6

312

1622

P18

ICPC

Medication abuse

4.4

26.5

147

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

6.3

26.5

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5.9

26.4

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

4.9

26.4

116

K92.1

ICD-10 Finland

Melaena

1.7

26.4

468

2764

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

26.4

260

1270

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.8

26.3

382

2128

J38.3

ICD-10 Finland

Other diseases of vocal cords

3.0

26.2

116

391

R06.4

ICD-10 Finland

Hyperventilation

2.8

26.2

132

478

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.8

26.2

405

2300

M10.9

ICD-10 Finland

Gout, unspecified

1.6

26.2

663

4289

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

9.4

26.2

B01AB05

ATC

enoxaparin; parenteral

1.3

26.1

2718

22444

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.2

26.0

221

1019

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

26.0

550

3404

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

26.0

216

987

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.4

26.0

271

ZXA00

NOMESCO Finland

Right side

1.3

25.8

2265

18281

R06.5

ICD-10 Finland

Mouth breathing

1.5

25.8

813

5519

SPAT1281

SPAT

Other administrative function

1.6

25.8

610

3882

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

25.8

754

5039

N61

ICD-10 Finland

Inflammatory disorders of breast

2.8

25.7

127

455

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

25.7

435

2536

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

4.3

25.7

151

GX1D5

NOMESCO Finland

Flow volume spirometry

6.3

25.7

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

5.6

25.6

J94.8

ICD-10 Finland

Other specified pleural conditions

2.5

25.6

157

628

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.2

25.5

160

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

4.1

25.5

173

D01

ICPC

Abdominal pain/cramps general

1.5

25.4

807

5486

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.3

25.4

201

900

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

4.8

25.4

120

ZXA05

NOMESCO Finland

Left side

1.3

25.3

2085

16676

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.9

25.3

121

426

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

3.6

25.3

228

E87.5

ICD-10 Finland

Hyperkalaemia

2.4

25.2

168

698

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

8.3

25.2

A10BJ06

ATC

semaglutide; parenteral

1.7

25.2

450

2663

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

4.4

25.2

145

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.4

25.2

178

760

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.7

25.1

125

P19

ICPC

Drug abuse

4.1

25.0

167

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.0

24.9

281

1441

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

24.9

178

763

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.9

24.9

115

397

SPAT1252

SPAT

Overall medication plan or its review

1.6

24.9

564

3553

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.4

24.8

169

710

PDQ22

NOMESCO Finland

Insertion of endovascular graft into a. iliaca externa

5.9

24.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

24.7

594

3794

L84

ICD-10 Finland

Corns and callosities

1.9

24.7

294

1536

PD4AD

NOMESCO Finland

CT of lower extremity arteries

3.3

24.7

280

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2.1

24.6

228

1089

A10AE05

ATC

insulin detemir; parenteral

1.7

24.5

451

2690

E, ,

ICD-9 Finland

4.1

24.5

165

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

24.5

5714

51673

P80

ICPC

Personality disorder

5.4

24.4

SPAT1360

SPAT

Extensive global examination

1.6

24.4

557

3514

ZXD35

NOMESCO Finland

Usual procedure

2.0

24.4

283

1466

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

8.2

24.3

R33

ICD-10 Finland

Retention of urine

1.5

24.3

753

5091

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.0

24.3

263

1329

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.9

24.3

116

408

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

5.2

24.3

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

4.8

24.3

113

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.4

24.2

166

699

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

24.2

652

4277

PEN24

NOMESCO Finland

Plastic repair of deep femoral artery

5.0

24.1

102

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

6.9

24.1

R05

ICD-10 Finland

Cough

1.3

24.1

1685

13154

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.7

24.1

203

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

1.9

24.0

282

1468

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

23.9

1842

14580

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

23.9

587

3768

SPAT1211

SPAT

Application of soft bandage

1.5

23.8

682

4534

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.2

23.8

191

861

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

5.1

23.7

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

4.6

23.7

123

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.9

23.7

316

1714

120

Kela drug reimbursment

Hypogammaglobulinaemia

7.2

23.7

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.0

23.6

248

1241

J01DC02

ATC

cefuroxime; systemic

1.7

23.6

430

2559

R4190

NOMESCO Finland

Nutritional therapy

1.9

23.6

295

1568

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.4

23.5

249

F22.0

ICD-10 Finland

Delusional disorder

2.7

23.5

126

472

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

3.4

23.4

245

N17.8

ICD-10 Finland

Other acute renal failure

2.7

23.4

123

456

E000006, ,

ATC

1.6

23.4

504

3135

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

23.3

822

5706

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

1.7

23.3

407

2393

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

6.8

23.3

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

7.3

23.3

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.4

23.2

154

639

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

6.2

23.1

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

23.1

207

976

L14

ICPC

Leg/thigh symptom/complaint

1.6

23.0

609

3977

R50

ICPC

Respiratory, Medication/prescr/renewal

6.4

23.0

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

3.6

23.0

214

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

23.0

258

1321

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

23.0

286

1518

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.2

22.9

192

881

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

6.9

22.9

SPAT1283

SPAT

Restricted health certificate

1.4

22.8

949

6799

E66.0

ICD-10 Finland

Obesity due to excess calories

2.9

22.8

107

373

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

22.8

229

1127

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.9

22.8

301

1628

A07AA09

ATC

vancomycin; oral

2.6

22.8

130

502

TUPKY, ,

NOMESCO Finland

3.5

22.8

225

TGA30

NOMESCO Finland

Thoracocentesis

3.4

22.7

235

8041/3-C34.1

ICD-O-3

Small cell carcinoma, NOS, of upper lobe, lung

8.6

22.7

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

22.7

451

2746

SPAT1097

SPAT

Recording of ECG

1.4

22.6

1224

9178

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

4.7

22.6

108

S20.2

ICD-10 Finland

Contusion of thorax

1.7

22.6

429

2583

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

22.5

797

5536

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

5.1

22.5

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

3.1

22.5

307

30088

ICD-8 Finland

Neuroses, Other

3.9

22.5

167

F2680, ,

NOMESCO Finland

7.0

22.4

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

6.0

22.4

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

22.4

278

1474

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

22.4

278

1474

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

3.6

22.4

204

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.7

22.4

121

455

EB4VA, ,

NOMESCO Finland

0.6

22.4

329

5649

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

22.3

1531

19388

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.5

22.3

134

531

R05DB20

ATC

other cough suppressants - combinations

1.7

22.3

405

2409

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

22.3

244

1240

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.0

22.3

330

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.8

22.3

114

417

I20.00

ICD-10 Finland

Unstable angina

1.9

22.1

263

1374

K29.1

ICD-10 Finland

Other acute gastritis

2.6

22.1

123

469

OAB48, ,

SPAT

0.6

22.1

355

5957

P73

ICPC

Affective psychosis

4.5

22.1

118

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.4

22.1

225

J01EA01

ATC

trimethoprim; systemic

1.3

22.1

1759

13974

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

9.0

22.1

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.3

22.0

164

717

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

22.0

2469

20496

7803A

ICD-9 Finland

General symptoms, Convulsions

3.3

22.0

245

ZZA00

NOMESCO Finland

Split skin graft

2.0

21.9

252

1302

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

4.1

21.9

144

53502

ICD-8 Finland

Gastritis and duodenitis, Gastritis acuta NUD

3.6

21.9

198

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.0

21.8

323

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

21.8

2080

16918

E970A

ICD-9 Finland

Injury due to legal intervention by firearms

6.3

21.8

UKC02

NOMESCO Finland

Cystoscopy

1.3

21.8

1488

11563

H02AB09

ATC

hydrocortisone; systemic

2.2

21.7

189

881

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

3.3

21.7

252

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.0

21.7

224

1114

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.5

21.7

136

550

A10BK03

ATC

empagliflozin; oral

1.4

21.7

868

6174

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

4.5

21.6

116

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

7.7

21.6

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

2.7

21.6

112

412

Z72.2

ICD-10 Finland

Drug use

5.1

21.6

A29

ICPC

General symptom/complaint other

1.4

21.5

974

7082

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

3.5

21.5

205

F60.8

ICD-10 Finland

Other specific personality disorders

4.0

21.4

155

N05AX13

ATC

paliperidone; systemic

4.4

21.4

121

M81.4

ICD-10 Finland

Drug-induced osteoporosis

4.4

21.4

121

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

6.2

21.4

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.7

21.4

116

437

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

21.4

1505

11741

SPAT1243

SPAT

Psychiatric/psychological examination

2.3

21.4

157

682

S01.0

ICD-10 Finland

Open wound of scalp

1.5

21.4

670

4541

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

21.4

776

5418

WX890

NOMESCO Finland

Intesive care monitoring

3.3

21.3

235

E66

ICD-10 Finland

Obesity

1.7

21.3

366

2144

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

5.2

21.2

R41.0

ICD-10 Finland

Disorientation, unspecified

1.9

21.2

251

1311

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

21.2

835

5922

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

7.2

21.2

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

21.2

753

5236

I51.7

ICD-10 Finland

Cardiomegaly

4.2

21.1

135

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

3.7

21.1

184

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.2

21.1

169

762

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.3

21.1

159

699

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

3.7

21.1

175

J05AH02

ATC

oseltamivir; oral

3.7

21.1

175

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

3.2

21.1

267

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.8

21.0

291

1598

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.9

21.0

258

1363

M70.2

ICD-10 Finland

Olecranon bursitis

1.8

21.0

340

1959

K00.09

ICD-10 Finland

Lack of teeth due to lack of dental development UNS

2.5

20.9

134

548

F32.8

ICD-10 Finland

Other depressive episodes

2.7

20.9

114

431

D75.1

ICD-10 Finland

Secondary polycythaemia

3.5

20.9

209

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.0

20.8

226

1145

P06

ICPC

Sleep disturbance

1.4

20.8

857

6127

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

20.8

2171

17847

D10

ICPC

Vomiting

1.8

20.8

307

1721

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

20.7

314

1773

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

20.7

838

5970

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

4.6

20.7

104

IGV01

NOMESCO Finland

Psychiatric network contact

3.8

20.7

168

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.8

20.7

168

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

20.7

243

1265

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

20.7

595

3960

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

20.5

3110

26674

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

20.5

663

4520

L04AA06

ATC

mycophenolic acid; systemic

2.2

20.5

171

784

UGC02

NOMESCO Finland

Rigid bronchoscopy

5.8

20.5

Z71.8

ICD-10 Finland

Other specified counselling

1.3

20.5

2305

19113

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

20.5

408

2488

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

20.4

536

3495

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

7.8

20.4

97940

ICD-8 Finland

Alcohol in combination with specified medicinal agents, With psychopharmacological agents

6.7

20.4

29580

ICD-8 Finland

Schizophrenia, Other

3.7

20.3

175

K56.0

ICD-10 Finland

Paralytic ileus

2.8

20.2

343

L05

ICPC

Flank/axilla symptom/complaint

1.6

20.2

468

2964

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

20.2

1030

7643

R05CA10

ATC

expectorants - combinations

2.2

20.1

171

790

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

20.1

474

3013

GX2D5

NOMESCO Finland

Sleep oximetry

3.5

20.1

200

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

20.1

363

2157

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

5.5

20.0

G02BA03

ATC

plastic IUD with progestogen

0.5

20.0

176

3534

N06AX26

ATC

vortioxetine; oral

1.6

20.0

440

2751

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.2

19.9

174

813

Angiography of the heart and coronary arteries

1.6

19.9

516

3354

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

19.9

1543

12196

D06AX01

ATC

fusidic acid; topical

1.5

19.8

671

4618

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

3.8

19.8

155

R5110, ,

SPAT

1.6

19.8

502

3246

R4120

NOMESCO Finland

Occupational therapy

1.6

19.8

520

3390

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

6.1

19.8

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.6

19.8

116

455

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.4

19.8

138

587

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

19.8

267

1456

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

5.4

19.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

19.7

534

3506

RS123, ,

NOMESCO Finland

6.4

19.6

J80

ICD-10 Finland

Adult respiratory distress syndrome

4.4

19.6

113

H26.3

ICD-10 Finland

Drug-induced cataract

3.3

19.6

213

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.1

19.6

181

865

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

19.6

2029

24438

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

19.5

363

2173

2918A

ICD-9 Finland

Alcoholic psychoses, Other specified alcoholic psychosis

5.1

19.5

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

24.6

19.5

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.9

19.4

323

280

Kela drug reimbursment

Clopidogrel

2.4

19.4

135

573

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000492) Spirometry study

2032

7472

3.15

307.65

1.9

1.4

—

(3003396) Base excess in Arterial blood by calculation

2570

9660

3.23

307.65

9.2

7.7

2.11

0.83

mmol/l

42.18

2206

7630

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2560

9695

3.20

307.65

9.3

7.6

5.50

5.03

kpa

66.08

2444

9257

(3023368) Bacteria identified in Blood by Culture

4292

23072

2.50

307.65

6.0

4.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1565

5159

3.41

307.65

5.6

3.3

5.50

5.07

kpa

49.47

1521

4862

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2179

8872

2.86

307.65

2.5

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2558

9690

3.20

307.65

9.3

7.6

9.84

12.72

kpa

212.82

2436

9241

(3009343) pH of Capillary blood

1541

5093

3.39

307.65

5.6

3.3

7.41

7.42

0.46

210

633

(3019060) Gas panel - Arterial blood

1791

5443

3.78

307.65

5.3

5.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3021

12959

2.90

307.65

2.6

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1055

2806

4.08

307.65

3.7

2.5

—

(4200892) Spirometry reversibility

1834

5489

3.86

307.65

1.8

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1407

4429

3.53

307.65

10.3

10.0

25.26

24.06

mmol/l

29.67

1348

4302

(3016502) Oxygen saturation in Arterial blood

2221

8793

2.96

307.65

9.6

8.1

93.16

96.02

59.96

2148

8461

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2165

8890

2.83

307.65

2.6

1.7

—

(3023419) Bacteria identified in Sputum by Culture

742

1088

7.28

307.65

3.0

2.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1503

4910

3.42

307.65

5.4

3.2

2.70

1.45

mmol/l

27.09

1217

3558

(3022313) Gas panel - Capillary blood

1119

3727

3.25

262.21

5.9

3.4

—

(3013115) Eosinophils [#/volume] in Blood

6010

42080

2.06

260.11

8.1

6.1

0.20

e9/l

1.01

5400

36749

(3015235) Bicarbonate [Moles/volume] in Capillary blood

757

1965

4.08

258.05

4.8

2.8

26.36

24.27

mmol/l

26.69

747

1920

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

524

1010

5.42

257.80

1.2

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4013

24381

2.07

256.31

3.7

2.9

1453.14

1377.54

ng/l

0.41

3518

20929

(40760892) CBC W Ordered Manual Differential panel - Blood

5568

38311

2.01

248.30

8.2

6.5

—

(3022096) Basophils/100 leukocytes in Blood

5413

36904

2.01

247.49

7.8

6.2

0.63

0.68

10.32

5137

34352

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1835

8191

2.52

247.07

10.9

8.5

126.46

121.38

g/l

18.10

1796

7958

(3019069) Monocytes/100 leukocytes in Blood

5561

38302

2.01

246.60

8.2

6.5

8.56

8.79

6.71

5296

35776

(3006315) Basophils [#/volume] in Blood

5814

40781

2.00

243.43

7.6

5.9

0.05

0.04

e9/l

25.91

5169

35138

(3006504) Eosinophils/100 leukocytes in Blood

5527

38093

2.00

243.37

7.9

6.1

2.55

2.93

29.30

5259

35505

(3001604) Monocytes [#/volume] in Blood

5801

40676

2.00

242.90

7.6

5.9

0.68

0.60

e9/l

92.32

5145

35080

(3005322) IgE [Units/volume] in Serum or Plasma

1174

4271

2.98

235.22

1.5

1.3

341.37

257.40

u/ml

1.30

1096

3935

(3019198) Lymphocytes [#/volume] in Blood

5869

41812

1.96

228.82

7.7

5.9

1.90

1.93

e9/l

0.62

5281

36833

(3002030) Lymphocytes/100 leukocytes in Blood

5593

39237

1.95

227.82

8.1

6.2

24.10

27.58

114.23

5320

36736

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

618

1547

4.19

220.65

1.7

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

618

1547

4.19

220.65

1.7

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

639

1651

4.06

218.54

4.4

2.7

7.61

8.19

kpa

18.13

623

1607

(3018010) Neutrophils/100 leukocytes in Blood

5478

38652

1.91

213.85

7.9

6.0

60.86

57.22

98.54

5223

36144

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

399

716

5.76

211.76

4.3

3.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

126

41.15

208.93

1.9

1.6

41.58

54.06

umol/l

1.16

126

(3002032) Base excess in Venous blood by calculation

1652

7662

2.38

201.01

5.0

4.1

2.80

1.73

mmol/l

17.26

1433

6461

(3000991) Gas panel - Venous blood

1570

7132

2.42

200.09

11.4

8.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1642

7676

2.36

195.83

5.0

4.0

6.23

5.76

kpa

38.43

1580

7465

(3012544) pH of Venous blood

1687

8015

2.33

193.63

4.9

4.0

7.39

7.37

0.76

(3021901) Oxygen saturation in Capillary blood

548

1394

4.10

191.06

4.0

2.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2498

13933

2.05

190.67

4.6

3.5

0.79

0.82

mmol/l

18.46

2329

13113

(3013650) Neutrophils [#/volume] in Blood by Automated count

6261

47144

1.86

188.80

11.8

9.3

5.04

4.09

e9/l

103.00

5626

41046

(3014111) Lactate [Moles/volume] in Serum or Plasma

1596

7513

2.34

186.62

10.3

7.3

1.36

1.38

mmol/l

0.34

1546

7303

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1217

5091

2.58

184.17

10.1

7.4

26.12

24.58

mmol/l

27.00

1205

5057

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5899

43910

1.83

181.21

7.6

6.6

10.51

11.98

umol/l

12.37

5622

41808

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5229

37681

1.80

177.44

9.4

6.3

1.20

1.21

mmol/l

23.40

4865

34443

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1238

5354

2.50

174.15

10.1

7.3

25.88

24.37

mmol/l

27.37

1190

5083

(3022217) INR in Platelet poor plasma by Coagulation assay

5540

40885

1.79

170.76

17.8

15.4

1.24

1.29

inr

3.66

1642

11675

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

606

1809

3.50

167.21

1.9

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

885

3307

2.84

166.61

6.2

3.5

25.33

24.69

mmol/l

8.21

841

3023

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5525

41410

1.74

154.90

9.9

7.1

1.20

1.21

mmol/l

30.66

4784

35159

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

612

1939

3.30

153.42

2.0

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1096

4743

2.47

152.97

2.2

1.6

—

(3042631) Mycobacterium sp identified in Specimen

441

1128

4.04

152.23

3.5

2.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2801

17329

1.85

151.68

2.1

1.7

1.16

1.28

mg/l

1.45

2222

13366

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

959

3915

2.60

151.30

4.9

4.5

24.70

23.95

mmol/l

7.52

927

3839

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

503

1430

3.65

149.23

1.9

1.4

—

(3042936) Bacteria identified in Isolate by Culture

2128

12123

1.96

147.91

2.5

2.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

590

1880

3.27

146.42

2.1

1.7

—

(1616796) Gas panel - Central venous blood

574

1814

3.29

144.35

5.4

3.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4925

36247

1.70

143.11

6.0

5.2

33.84

35.42

g/l

64.73

4590

33738

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1193

5537

2.31

141.64

12.8

9.3

1.86

1.32

30.46

1186

5500

(3014007) Fractional oxyhemoglobin in Arterial blood

1199

5586

2.30

141.06

13.0

9.4

91.11

94.25

39.01

1194

5569

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1189

5534

2.30

140.15

12.9

9.4

0.61

0.67

7.01

1181

5497

(3006184) Hemoglobin [Mass/volume] in Capillary blood

562

1792

3.26

139.20

2.7

2.2

133.15

129.81

g/l

1.85

370

1283

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

418

1127

3.83

133.86

1.9

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2627

16499

1.80

132.29

5.3

3.7

403.17

571.73

ng/l

1.04

2133

13227

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1392

7066

2.13

131.83

3.6

2.8

233.36

196.47

ng/l

1.63

1269

6419

(3013826) Glucose [Moles/volume] in Serum or Plasma

6266

49907

1.67

128.61

8.5

4.8

6.94

6.82

mmol/l

4.04

5979

47009

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1053

4823

2.32

128.32

13.2

10.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3777

26470

1.68

127.35

3.4

2.6

70.73

67.19

u/l

0.08

3473

24511

(3024354) Oxygen [Partial pressure] in Venous blood

1258

6262

2.15

124.90

4.5

3.2

4.81

4.61

kpa

1.81

1193

6067

(3007853) Bacteria identified in Skin by Aerobe culture

1733

9715

1.95

123.93

2.1

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

215

358

6.11

123.05

4.3

3.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1013

4645

2.31

122.89

1.8

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

8404

91470

0.52

120.60

40.1

21.5

135.15

136.90

g/l

18.68

8293

90168

(3026361) Erythrocytes [#/volume] in Blood

8403

91455

0.52

120.29

39.8

21.4

4.48

4.52

e12/l

10.42

8203

88790

(3024731) MCV [Entitic volume]

8404

91449

0.52

119.73

39.6

21.3

92.11

91.31

41.79

8295

90149

(3035941) MCH [Entitic mass]

8403

91440

0.52

119.67

39.6

21.3

30.47

0.02

8294

90140

(3010813) Leukocytes [#/volume] in Blood

8407

91454

0.52

119.01

39.8

21.4

8.01

6.68

e9/l

231.30

8208

88770

(3007461) Platelets [#/volume] in Blood

8401

91397

0.52

118.52

39.8

21.4

262.10

243.76

e9/l

93.44

8232

89018

(3020779) Urea [Moles/volume] in Serum or Plasma

1486

8030

2.00

117.70

8.8

7.9

9.95

10.18

mmol/l

0.60

1419

7672

(3009542) Hematocrit [Volume Fraction] of Blood

8404

91341

0.52

115.32

40.4

21.5

40.48

40.76

1.31

7821

85303

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4388

32536

1.62

114.73

5.3

3.5

61.68

76.71

ng/l

0.23

3361

23258

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1907

11293

1.85

114.22

7.1

6.4

1.07

1.03

mmol/l

5.89

1787

10559

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

447

1406

3.28

112.94

2.1

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

418

1261

3.41

112.92

1.6

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

383

1099

3.58

111.77

1.1

1.53

1.52

g/l

0.18

348

995

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1691

9721

1.89

110.89

2.4

1.8

1.81

1.50

25.13

1416

8433

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3771

27253

1.61

107.54

4.2

3.3

37.34

35.87

u/l

0.27

3550

25786

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

417

1308

3.28

105.78

2.0

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

417

1308

3.28

105.78

2.0

1.7

—

(3010421) pH of Blood

579

2195

2.74

104.88

6.9

3.8

7.42

0.89

525

2001

(3027315) Oxygen [Partial pressure] in Blood

525

1907

2.85

103.12

6.9

3.9

8.14

8.67

kpa

11.11

514

1870

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

202

377

5.45

102.52

15.6

17.6

1473.75

1440.97

nmol/l

0.19

193

368

(3012501) Base excess in Blood by calculation

520

1895

2.84

101.50

6.9

3.8

3.06

2.41

mmol/l

5.07

420

1255

(3013290) Carbon dioxide [Partial pressure] in Blood

520

1895

2.84

101.50

6.9

3.8

5.34

4.94

kpa

17.89

509

1859

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

368

1104

3.42

100.21

2.1

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

710

3046

2.43

99.50

2.7

2.3

458.70

693.81

ug/l

1.20

668

2873

(3019977) pH of Arterial blood

207

409

5.15

98.58

2.6

2.8

7.42

0.79

129

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1122

5831

2.04

97.98

1.8

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

365

1113

3.36

96.84

1.6

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

496

1809

2.83

96.61

1.4

1.1

—

(3000494) Fungus identified in Specimen by Culture

1659

9865

1.82

96.35

2.0

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7643

84651

0.60

95.46

5.6

5.2

2.52

2.73

mmol/l

70.48

6938

78140

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

317

893

3.63

95.03

2.4

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

363

1125

3.31

93.82

6.0

4.6

361.71

361.24

umol/l

0.02

319

952

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

211

444

4.83

93.36

1.6

1.3

1.99

1.32

u/ml

0.49

139

247

(40767503) Oxygen content in Capillary blood by calculation

477

1747

2.82

92.13

3.6

2.4

16.31

16.45

0.28

284

882

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

766

3511

2.28

92.07

2.3

2.0

1.90

2.23

ug/l

0.41

702

3124

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1408

8076

1.86

91.49

2.3

0.21

g/l

0.04

1295

7537

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

355

1110

3.28

90.43

1.8

1.9

25.13

24.78

ug/l

0.03

347

1082

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7481

83073

0.62

90.01

5.1

4.6

4.40

4.61

mmol/l

57.67

6811

77139

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

186

364

5.19

89.55

10.8

12.8

841.93

861.88

nmol/l

0.18

179

346

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1251

6975

1.91

88.57

2.6

2.3

348.91

371.14

nmol/l

2.61

1131

6444

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7419

82484

0.62

88.55

5.0

4.6

1.36

1.43

mmol/l

34.78

6709

76104

(3028707) Methadone [Presence] in Urine by Screen method

272

729

3.81

87.70

3.1

2.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

299

881

3.47

83.69

2.2

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

299

881

3.47

83.69

2.2

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

490

1913

2.64

83.49

2.5

3.0

33.74

35.01

umol/l

0.54

445

1718

(3018418) pH of Serum or Plasma

3334

24482

1.54

83.01

5.2

4.3

7.40

0.40

696

4726

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

725

3391

2.23

82.74

2.6

2.0

—

(3020891) Body temperature

730

3444

2.21

81.53

7.6

4.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

667

3048

2.27

80.48

6.4

4.0

1.40

mmol/l

0.01

657

2999

(40758558) Short blood count panel - Blood

2906

20847

1.55

79.72

8.7

7.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

668

3108

2.23

77.09

2.4

1.8

—

(3026008) Bacteria identified in Urine by Culture

3113

22824

1.53

76.63

3.7

3.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2783

20055

1.54

73.62

2.6

2.2

3.24

2.94

mg/l

6.77

2412

17118

(3026782) Osmolality of Urine

2415

16876

1.57

73.33

3.5

2.9

512.39

558.45

mosm/kgh2o

19.31

2091

14526

(3005719) IgG [Mass/volume] in Serum or Plasma

1088

6154

1.86

72.83

2.9

2.8

9.85

10.63

g/l

8.15

1010

5620

(3017569) Oxygen content in Arterial blood

164

348

4.77

71.87

2.4

2.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3459

26258

1.48

70.52

2.8

2.2

254.35

215.51

u/l

1.15

3243

24619

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

206

530

3.95

70.38

1.3

1.1

—

(3047181) Lactate [Moles/volume] in Blood

595

2740

2.24

70.28

7.7

6.5

1.30

1.33

mmol/l

0.38

540

2402

(3019309) Folate [Moles/volume] in Red Blood Cells

2219

15350

1.57

69.93

1.9

1.7

1108.94

1164.42

nmol/l

2.08

1651

11679

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

228

636

3.64

69.35

2.5

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

890

4800

1.94

68.78

1.9

1.20

1.34

g/l

1.28

815

4359

(3022948) Iron [Moles/volume] in Serum or Plasma

1957

13192

1.60

68.75

3.0

2.6

11.53

13.31

umol/l

17.30

1825

12352

(1761868) Lipid panel - Serum or Plasma

2118

29532

0.64

68.19

3.4

3.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8238

88548

0.62

67.70

15.4

10.7

27.45

27.65

u/l

0.26

7990

85411

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7234

79853

0.67

66.48

4.5

4.2

1.49

1.32

mmol/l

48.84

6480

73099

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1746

11552

1.62

65.97

3.1

2.7

19.99

23.37

17.12

1498

9862

(3009445) Proteinase 3 Ab [Units/volume] in Serum

715

3633

2.04

65.43

1.3

1.6

6.17

16.31

u/ml

2.44

100

(3037692) Legionella sp identified in Specimen by Organism specific culture

140

284

4.98

64.73

2.2

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

347

1298

2.73

64.22

2.4

1.8

1.58

1.77

mmol/l

4.15

340

1264

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1822

12274

1.59

63.60

3.0

2.6

2.34

2.29

g/l

2.86

1684

11409

(3027273) Bicarbonate [Moles/volume] in Venous blood

762

4025

1.97

62.40

4.8

3.5

26.34

25.02

mmol/l

13.82

742

3903

(46235355) HIV 1 and 2 tests - Meaningful Use set

1570

10251

1.63

62.24

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1629

23567

0.63

60.26

2.7

3.0

0.68

0.76

ug/l

1.87

1093

15914

(3000850) Epithelial cells [#/volume] in Urine

2462

17910

1.50

59.99

3.3

2.6

6.07

4.37

e6/l

7.27

2223

16116

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1949

13563

1.54

58.36

2.4

2.1

30.44

30.02

2.17

1896

13186

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2462

32506

0.68

57.60

3.8

4.3

20.49

21.88

4.03

1042

16175

(3017181) Myelocytes/100 leukocytes in Blood

1162

7164

1.70

57.15

4.5

4.1

0.98

0.96

0.09

488

2564

(3002582) Erythrocytes [#/volume] in Urine

3328

25864

1.43

56.72

4.3

3.3

54.90

94.27

e6/l

2.73

2646

20006

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1235

7756

1.67

56.63

3.2

2.5

32.18

56.87

u/l

1.55

1041

6680

(3003181) Sodium [Moles/volume] in Urine

343

1362

2.57

56.32

1.5

1.3

53.18

65.69

mmol/l

6.05

241

1085

(3036180) Methadone [Presence] in Urine

118

233

5.11

56.31

2.3

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

2870

21774

1.44

55.54

6.0

4.0

89.21

88.33

0.99

2783

21270

(3004119) Hemoglobin [Mass/volume] in Venous blood

895

5166

1.80

55.40

4.7

3.4

129.97

129.38

g/l

0.31

871

5033

(3022806) Fractional oxyhemoglobin in Capillary blood

287

1060

2.76

54.43

2.3

1.8

88.55

89.56

2.33

282

1045

(3011288) Drugs identified in Urine by Screen method

283

1041

2.77

54.09

3.3

2.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1067

6526

1.71

53.87

4.1

3.9

0.75

0.70

0.18

430

2230

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1504

10080

1.58

52.66

3.6

4.6

240.04

245.14

u/l

0.56

1411

9554

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

486

2314

2.16

52.64

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

322

1284

2.56

52.42

3.0

1.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

214

691

3.14

51.69

1.6

1.3

1.51

1.37

promille

0.63

169

527

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

135

320

4.26

51.58

2.2

1.8

120.16

118.24

umol/l

0.03

152

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1457

9753

1.58

51.16

2.7

2.9

9.25

9.30

umol/l

0.02

1215

8632

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

205

652

3.19

50.79

1.9

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

589

3055

1.99

50.61

3.5

3.1

0.31

0.34

u/ml

1.81

344

1752

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7252

64959

1.41

50.36

10.5

7.8

82.60

79.06

u/l

5.83

6923

61265

(3031040) Bacteria [#/volume] in Urine by Automated count

6091

53036

1.37

49.91

5.9

4.2

1215.30

998.73

e6/l

0.11

117

774

(3021440) Promyelocytes/100 leukocytes in Blood

1085

6796

1.67

49.89

4.6

4.1

0.11

0.12

0.20

413

2203

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

7.57

49.54

3.3

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1446

9740

1.57

49.25

2.7

2.5

1.92

1.75

6.28

1272

8665

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3798

30751

1.38

48.88

4.2

3.3

—

0.45

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

648

3528

1.89

48.18

6.8

5.5

2.29

1.61

19.03

614

3282

(3003338) MCHC [Mass/volume]

6203

69188

0.73

47.16

36.7

18.6

330.14

333.08

g/l

99.73

6130

68720

(3030467) Casts [#/volume] in Urine by Automated count

3027

23750

1.39

46.61

4.1

3.2

0.64

0.43

e6/l

2.99

2389

18172

(3015377) Calcium [Moles/volume] in Serum or Plasma

3419

27386

1.38

46.35

3.6

2.35

mmol/l

0.33

2971

24141

(3052851) Hemolysis interference index of Serum or Plasma

496

2496

2.04

46.34

4.4

3.3

—

(36304419) Bacteria [Presence] in Urine

2929

22879

1.39

46.23

4.1

3.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

545

2840

1.97

46.14

1.6

130.91

297.95

titre

1.96

110

(3016879) Cocaine [Presence] in Urine

353

1559

2.31

45.90

3.0

1.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4139

34203

1.36

45.87

2.2

2.0

90.43

94.86

pmol/l

7.82

2360

18291

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

162

475

3.45

45.77

1.8

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

308

1287

2.44

45.39

1.6

0.69

0.86

g/l

1.69

230

962

(3028192) IgG subclass 2 [Mass/volume] in Serum

223

798

2.84

44.93

1.6

1.4

2.53

2.96

g/l

3.18

157

542

(21494755) Public health laboratory ask at order entry panel

319

6862

0.45

44.71

1.3

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

323

6905

0.45

44.52

1.7

1.9

—

(3025159) Blasts/100 leukocytes in Blood

1014

6419

1.64

44.47

4.7

4.1

0.12

0.35

1.23

342

1847

(3024928) Oxygen saturation in Venous blood

387

1800

2.20

44.42

3.9

3.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

222

798

2.82

44.36

1.6

1.4

0.40

g/l

0.12

158

543

(3027135) IgG subclass 1 [Mass/volume] in Serum

222

799

2.82

44.26

1.6

1.4

6.18

6.90

g/l

2.23

156

544

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

159

473

3.40

43.94

1.8

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

543

3.22

43.86

1.8

1.4

—

(3018095) Leukocytes [#/volume] in Urine

3623

29499

1.36

43.50

5.0

3.7

94.17

87.14

e6/l

0.22

2744

21428

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

206

720

2.90

43.36

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

206

720

2.90

43.36

1.5

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

206

720

2.90

43.36

1.5

1.8

—

(4062490) Immunoglobulin typing, IgG

219

798

2.78

42.67

1.6

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

321

1407

2.32

42.48

3.3

2.9

0.83

0.80

nmol/l

0.52

254

1043

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

6.77

42.30

1.5

1.2

57.18

36.99

mg/l

1.74

(3000764) Benzodiazepines [Presence] in Urine

362

1675

2.20

42.09

3.1

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1926

14174

1.44

41.95

1.6

1.5

2.69

2.57

g/l

0.95

1183

8667

(3007930) Methemoglobin/Hemoglobin.total in Blood

616

3464

1.83

41.23

7.0

5.6

0.86

0.90

1.47

583

3228

(3028300) Cannabinoids [Presence] in Urine

362

1691

2.18

41.10

3.1

1.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

653

3741

1.80

41.10

5.8

3.8

52.09

48.49

3.27

643

3697

(3027008) Opiates [Presence] in Urine

361

1685

2.18

41.07

3.0

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1166

7794

1.56

40.52

2.9

2.3

7.93

8.38

ug/l

0.25

1019

6901

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

216

804

2.72

40.42

2.0

1.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

453

2318

2.00

40.36

1.4

10.34

14.48

iu/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

223

862

2.62

38.74

1.9

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1278

8813

1.52

38.36

4.6

3.4

—

(3039000) Anion gap in Blood

396

1967

2.05

38.31

8.3

7.7

10.80

11.30

mmol/l

2.01

366

1755

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7602

81508

0.73

38.30

5.5

4.8

6.31

6.03

mmol/l

39.11

6857

74366

(3018572) Chloride [Moles/volume] in Blood

396

1968

2.05

38.25

8.3

7.7

103.96

105.44

mmol/l

6.66

366

1756

(3013707) Erythrocyte sedimentation rate by Westergren method

6758

60877

1.33

38.06

5.6

4.0

16.08

12.15

mm/h

61.41

6299

56221

(3027944) Amphetamines [Presence] in Urine

349

1657

2.15

38.03

3.2

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3385

40508

0.75

37.42

4.2

5.0

3.33

3.29

ug/l

0.01

2915

36543

(40757373) Influenza virus identified in Isolate

151

5.13

37.13

2.3

1.5

—

(40761511) CBC panel - Blood by Automated count

8065

85569

0.71

36.92

25.1

13.7

—

(3037522) Nuclear Ab [Titer] in Serum

1474

10552

1.46

36.63

1.4

1.3

475.38

515.35

titre

0.39

329

2151

(3021960) Folate [Moles/volume] in Serum or Plasma

2446

19131

1.37

36.61

1.7

1.5

18.53

20.23

nmol/l

5.70

2124

16384

(3040151) Glucose [Moles/volume] in Capillary blood

225

903

2.53

36.20

37.1

6.7

8.16

7.46

mmol/l

0.59

192

727

(3009508) Creatinine [Moles/volume] in Urine

3405

28044

1.32

35.89

3.5

3.2

7.16

7.92

mmol/l

18.42

2774

23595

(3021589) Normoblasts [#/volume] in Blood

4276

36390

1.30

35.33

14.0

9.8

0.01

0.00

e9/l

0.42

3524

29877

(3017143) Hepatitis C virus Ab [Presence] in Serum

1172

8072

1.51

35.20

1.7

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

161

4.81

34.50

1.6

2.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

338

1648

2.09

34.38

1.2

53.33

210.00

titre

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1070

7278

1.53

34.02

2.0

2.6

65.11

66.54

g/l

7.22

987

6646

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

443

2407

1.88

33.01

2.8

2.6

3.80

3.59

g/l

1.93

417

2295

(3020682) Albumin/Creatinine [Ratio] in Urine

3420

28490

1.30

32.25

4.0

3.9

16.46

8.74

mg/mmol

6.79

2223

18370

(3044242) Glucose [Moles/volume] in Arterial blood

123

382

3.25

31.84

2.4

2.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

468

2644

1.81

30.77

1.9

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

169

639

2.67

30.76

1.6

1.4

11.56

12.70

u/l

1.54

164

617

(3044640) Blood type and Crossmatch panel - Blood

3190

26498

1.30

30.24

3.0

2.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1927

14911

1.36

29.97

3.3

3.2

2.48

2.45

mmol/l

19.54

1648

13111

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

197

4383

0.44

29.82

1.3

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1235

8875

1.45

29.60

1.7

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1788

13712

1.37

29.37

3.7

3.0

2.64

1.82

e6/l

3.49

1021

7573

(3037467) Urinalysis macro (dipstick) panel - Urine

6215

56212

1.27

29.12

5.5

4.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

147

538

2.76

28.53

1.9

1.6

—

(40768797) Stomach Pathology biopsy report

1546

11640

1.39

28.34

1.4

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

229

3.78

28.20

3.3

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

229

3.78

28.20

3.3

2.8

—

(3012516) Albumin [Mass/volume] in Urine

3234

27117

1.28

27.95

3.4

3.3

395.25

383.24

mg/l

0.05

2174

17644

(3016038) Potassium [Moles/volume] in Urine

139

500

2.80

27.89

1.2

32.52

34.66

mmol/l

0.46

117

430

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3754

32117

1.27

27.39

3.4

2.8

147.28

160.71

ug/l

1.77

3431

29580

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

270

1321

2.07

27.26

1.3

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

248

1178

2.13

27.07

1.4

1.5

35.63

32.97

g/l

2.73

218

1062

(3000570) Elastase.pancreatic [Mass/mass] in Stool

436

2508

1.77

26.97

1.5

1.4

268.79

267.53

ug/g

0.04

262

1488

(3023199) Leukocytes [#/volume] in Pleural fluid

224

1033

2.19

26.36

1.4

1.5

5391.70

2041.20

e6/l

1.03

168

739

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

255

1239

2.09

26.24

6.2

6.6

11.53

11.56

mg/l

0.03

231

1148

(3008757) Leukocyte morphology finding [Identifier] in Blood

206

924

2.26

25.94

3.2

4.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

435

2530

1.75

25.90

2.7

2.2

90.41

89.89

0.17

420

2429

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2498

20420

1.30

25.90

2.9

2.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

8283

86769

0.75

25.67

32.9

16.9

4.01

3.99

mmol/l

9.18

8122

84616

(3019225) pH of Specimen

1150

8360

1.42

25.66

4.4

4.5

—

(3042733) HLA Ab [Presence] in Serum

100

313

3.22

25.64

4.5

5.1

—

(3023520) Reticulocytes [#/volume] in Blood

1039

7419

1.45

25.57

2.5

2.7

75.55

69.01

e9/l

6.22

770

5700

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

122

433

2.84

25.14

1.5

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

122

433

2.84

25.14

1.5

2.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

226

3.60

24.86

2.6

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3726

32115

1.25

24.75

2.6

2.2

73.35

77.61

nmol/l

14.76

3297

28837

(44816559) Phosphatidylethanol [Mass/volume] in Blood

276

1411

1.98

24.71

1.6

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

7.75

24.63

1.4

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

329

1787

1.87

24.58

11.5

5.5

345.22

2072.89

iu/ml

1.09

270

(3051651) Icteric interference index of Serum or Plasma

134

507

2.67

24.45

4.9

4.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

279

1443

1.96

24.17

2.6

3.5

1.29

1.62

1.05

246

1286

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

319

1726

1.88

24.13

1.7

1.6

—

(3036489) Thrombin time

496

3056

1.66

23.87

2.5

2.1

21.25

21.60

0.57

438

2687

(3012441) Differential panel - Pleural fluid

196

894

2.22

23.74

1.4

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

8275

86530

0.76

23.42

33.0

16.8

138.98

139.75

mmol/l

105.55

8121

84521

(3024666) Lithium [Moles/volume] in Serum or Plasma

108

379

2.87

22.77

14.8

11.9

0.64

0.65

mmol/l

0.14

102

349

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

390

2283

1.74

22.72

1.6

0.24

g/l

0.11

366

2160

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5963

54453

1.23

22.18

4.6

3.1

70.09

53.30

u/l

17.45

5535

50531

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7486

79148

0.79

22.01

24.7

13.7

82.30

79.35

ml/min/173m2

25.59

6444

65916

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

180

819

2.22

21.97

1.3

778.73

452.36

u/l

0.44

173

778

(3028308) Erythrocytes [#/volume] in Pleural fluid

198

937

2.14

21.90

1.4

1.5

92660.86

58962.00

e6/l

0.33

125

548

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1213

9130

1.37

21.85

3.0

4.4

21.69

24.93

ug/l

0.19

1075

7530

(3039443) Prostate specific Ag panel - Serum or Plasma

2353

0.35

21.80

1.5

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

386

2293

1.71

21.34

2.9

2.5

206.85

197.36

1.22

364

2181

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

396

2371

1.70

21.27

1.6

1.20

1.19

g/l

0.46

373

2252

(3001019) Free T4 and TSH panel - Serum or Plasma

159

3351

0.47

20.77

1.5

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

205

1019

2.03

19.94

1.6

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

147

644

2.30

19.68

1.2

1.3

13.76

12.87

u/l

0.19

137

597

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1824

14763

1.29

19.62

3.5

2.8

1.18

1.04

e6/l

0.70

1059

8558

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

847

6122

1.42

19.31

4.5

4.2

103.62

94.31

ng/l

1.54

724

5328

(3026389) Candida sp identified in Specimen by Organism specific culture

210

1066

1.99

19.28

1.5

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

325

2.85

19.23

1.6

1.4

1128540.90

1319331.79

iu/ml

—

(40768806) Pleura Pathology biopsy report

189

926

2.06

19.14

1.5

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

534

3534

1.54

19.02

2.0

1.9

38.36

39.11

u/l

0.37

456

3094

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

258

3.08

18.98

2.9

2.4

152.00

145.63

nmol/l

0.25

222

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

586

3965

1.51

18.82

1.6

1.7

1.71

1.53

g/l

4.58

504

3389

(3051611) Lipemic interference index of Serum or Plasma

182

885

2.08

18.81

4.5

3.4

—

(3008295) Osmolality of Serum or Plasma

172

820

2.12

18.73

1.3

1.4

273.49

280.54

mosm/kgh2o

2.57

131

654

(3013512) EKG study

2966

25505

1.23

18.72

5.1

3.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

745

5292

1.44

18.68

1.5

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

175

846

2.09

18.38

1.1

1.0

2.09

1.15

u/ml

1.23

104

397

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

250

1375

1.84

18.05

4.7

2.7

581.00

7546.11

u/ml

0.60

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

366

2247

1.65

17.91

2.2

2.0

11.33

11.56

mg/l

0.19

341

2087

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

378

2341

1.64

17.87

1.6

2.52

6.42

iu/ml

0.51

517

(3026493) Urate [Moles/volume] in Serum or Plasma

2789

23923

1.23

17.85

3.5

2.7

3067.78

4440.99

umol/l

1.16

2391

21000

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

6.68

17.83

2.3

3.6

1.78

2.51

mg/l

1.02

(3017354) Segmented neutrophils/100 leukocytes in Blood

179

883

2.05

17.83

2.4

3.5

60.43

56.76

1.54

149

754

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

198

1013

1.97

17.81

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

288

1662

1.75

17.71

1.5

16.81

17.30

u/ml

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

162

773

2.11

17.63

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2134

17804

1.25

17.59

1.8

1.7

50287448.08

30674025.64

pmol/l

0.62

1742

14801

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

264

1491

1.79

17.48

1.6

1.5

119.31

115.46

u/ml

0.29

305

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

287

1663

1.75

17.41

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

827

6074

1.39

17.14

1.8

2.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

335

2.70

17.09

1.6

2.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.86

16.95

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

119

511

2.34

16.76

1.7

2.8

0.24

e9/l

0.03

100

450

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

333

2.69

16.74

1.6

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

333

2.69

16.74

1.6

2.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

303

2.75

16.38

1.0

1.1

5.85

4.08

u/ml

0.39

(3024932) HLA-DR beta [Type]

315

2.71

16.30

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

122

537

2.29

16.24

1.7

2.7

591.12

523.09

e6/l

0.78

100

453

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7450

78207

0.82

16.22

7.5

6.0

42.26

40.21

mmol/mol

50.68

6806

72338

(3048929) Epstein Barr virus Ab [Presence] in Serum

334

2063

1.64

15.99

1.2

—

(3042517) Benzodiazepines panel - Urine

6.36

15.80

4.3

1.8

—

(3036782) Glucose [Moles/volume] in Pleural fluid

161

804

2.02

15.56

1.3

1.4

6.57

6.33

mmol/l

0.39

151

735

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

476

3217

1.50

15.39

2.0

2.4

3.17

2.90

g/l

6.91

430

2889

(3045788) Cell count panel - Pleural fluid

159

798

2.01

15.17

1.4

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

198

1076

1.86

14.93

1.1

1.71

1.67

u/ml

0.02

115

533

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.78

14.84

1.2

1.1

—

(3024471) HLA-A [Type]

321

2.60

14.68

1.0

—

(3017732) Neutrophils [#/volume] in Blood

767

5709

1.37

14.62

3.8

2.9

6.73

4.89

e9/l

1.63

584

4589

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

293

2.68

14.62

1.2

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

900

6872

1.34

14.54

5.1

4.1

1.21

1.23

mmol/l

6.06

821

6041

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

498

3442

1.47

14.42

2.0

2.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

192

1046

1.85

14.38

2.4

1.9

28.29

26.76

mg/l

0.13

267

(3003888) Timothy IgE Ab [Units/volume] in Serum

179

954

1.89

14.35

1.1

4.91

4.35

u/ml

0.14

100

445

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

498

3447

1.47

14.31

2.0

2.4

7.91

7.29

g/l

11.20

452

3114

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

496

3438

1.47

14.16

2.0

2.4

3.96

3.69

g/l

1.51

450

3110

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

159

3.28

14.03

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

107

476

2.26

13.96

2.7

2.2

14.94

47.88

umol/l

1.38

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

390

2586

1.53

13.83

2.1

2.3

0.10

0.03

g/l

0.41

364

2345

(40768800) Prostate Pathology biopsy report

140

2679

0.52

13.81

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

173

924

1.89

13.80

1.0

1.1

0.90

1.16

u/ml

0.30

375

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

431

2921

1.50

13.78

2.1

2.5

0.60

0.93

g/l

1.15

379

2502

(3010375) cycloSPORINE [Mass/volume] in Blood

424

2.32

13.65

41.6

25.7

146.27

113.05

ug/l

3.79

348

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

398

2658

1.52

13.65

2.1

2.3

36.20

37.94

g/l

6.79

351

2323

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

259

1566

1.67

13.54

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

200

1125

1.79

13.53

1.2

1.1

114.20

117.42

0.68

186

1008

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.87

13.50

1.4

1.6

0.36

1.16

mg/l

0.69

(3007566) Smooth muscle Ab [Titer] in Serum

356

2330

1.55

13.41

1.2

122.26

143.33

titre

0.17

207

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

365

2405

1.54

13.33

2.2

2.4

0.00

g/l

0.35

339

2170

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

462

3196

1.47

13.33

2.0

2.4

9.51

10.28

g/l

3.56

415

2852

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1883

15911

1.23

13.32

1.3

1.2

1.59

1.96

u/ml

0.63

444

4258

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

104

468

2.23

13.23

1.6

1.3

—

(3011412) CD3 cells [#/volume] in Blood

151

783

1.94

13.19

1.7

2.5

1.30

1.14

e9/l

1.26

132

710

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

359

2364

1.54

13.16

2.2

2.4

0.00

g/l

-0.00

336

2162

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.91

13.04

1.4

1.6

3.05

1.26

mg/l

0.63

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.91

13.04

1.4

1.6

0.93

0.55

mg/l

0.25

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.91

13.04

1.4

1.6

1.70

1.75

mg/l

0.02

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.91

13.04

1.4

1.6

0.95

0.74

mg/l

0.13

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.91

13.04

1.4

1.6

4.06

2.01

mg/l

0.75

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.91

13.04

1.4

1.6

2.27

3.43

mg/l

0.42

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.91

13.04

1.4

1.6

0.72

1.42

mg/l

0.53

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.91

13.04

1.4

1.6

2.32

2.01

mg/l

0.09

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.91

13.04

1.4

1.6

1.82

2.37

mg/l

0.20

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

333

2166

1.56

12.91

1.4

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

242

1461

1.67

12.75

1.2

316.36

285.98

u/ml

0.68

157

916

(3023430) Cat dander IgE Ab [Units/volume] in Serum

134

678

1.99

12.58

1.1

1.0

7.34

2.69

u/ml

1.35

254

(3034770) Mitochondria Ab [Titer] in Serum

348

2302

1.53

12.51

1.2

683.75

922.13

titre

0.52

(3035880) pH of Pleural fluid

105

486

2.17

12.49

1.2

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

124

616

2.03

12.26

1.8

2.6

804.88

612.93

e6/l

3.06

117

589

(3015171) Extractable nuclear Ab [Units/volume] in Serum

424

2947

1.46

11.97

1.3

1.2

0.51

0.94

u/ml

0.80

279

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1577

13236

1.23

11.77

1.3

53.43

34.36

iu/ml

2.99

523

4212

(3014133) Dog dander IgE Ab [Units/volume] in Serum

139

736

1.90

11.47

1.1

1.0

6.14

3.17

u/ml

1.04

327

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

199

1174

1.71

11.47

1.3

1.2

2.98

4.05

u/ml

1.50

500

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

198

1168

1.71

11.42

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

152

832

1.84

11.32

2.5

3.1

—

(3011648) Oxygen content in Venous blood

130

678

1.93

11.23

2.5

2.3

11.00

11.30

0.30

130

678

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

303

1993

1.54

11.22

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

201

1198

1.69

11.17

1.3

1.2

2.25

3.35

u/ml

1.15

381

(3006245) CD3-CD19+ cells/100 cells in Blood

274

2.49

11.16

1.5

2.3

10.43

11.21

0.25

244

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

387

2.23

11.02

1.5

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

144

3.06

10.70

1.2

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.71

10.69

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

233

1460

1.61

10.67

1.3

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

153

860

1.79

10.48

1.2

1.1

93.77

97.87

1.27

143

798

(3006576) Bicarbonate [Moles/volume] in Blood

339

2.28

10.41

5.4

6.8

26.37

25.10

mmol/l

1.45

302

(3014271) Vancomycin [Susceptibility]

412

2.15

10.26

3.1

2.9

—

(3000060) B lymphocytes [#/volume] in Blood

181

2.77

10.18

1.4

2.3

195.15

632.45

e6/l

0.56

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

664

8530

0.76

10.06

1.5

1.4

—

(40761536) Microorganisms panel - Urine sediment

854

6806

1.28

10.02

4.8

3.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

274

1811

1.53

9.97

1.4

—

(3011985) Renin [Units/volume] in Plasma

191

1159

1.66

9.97

1.2

1.4

84.15

62.19

mu/l

0.66

168

1025

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

205

1267

1.63

9.95

1.9

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.66

9.95

1.2

—

(3028433) Virus identified in Specimen by Culture

284

2.37

9.90

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

322

2209

1.47

9.79

1.2

—

(3037756) Immunofixation for Serum or Plasma

284

1902

1.51

9.72

1.3

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

111

578

1.93

9.70

1.5

1.6

17.91

25.15

u/ml

1.34

124

(3014765) Yersinia sp identified in Stool by Organism specific culture

320

2198

1.47

9.67

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4946

46158

1.14

9.46

3.2

2.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

100

1872

0.53

9.32

1.5

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

1074

8867

1.24

9.27

2.3

201.43

147.52

ug/g

1.44

843

7084

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

178

1082

1.66

9.26

1.2

1.4

225.30

416.45

pmol/l

1.29

147

925

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

138

782

1.78

9.26

1.1

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

109

575

1.91

9.19

1.6

2.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

405

2.08

9.13

35.8

33.9

8.16

7.35

ug/l

2.77

369

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

315

2184

1.46

9.10

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

574

4396

1.32

9.09

3.2

3.4

4.31

4.45

pmol/l

2.87

500

3919

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

173

1051

1.66

9.03

1.4

1.5

—

(36660697) Celiac disease serology panel - Serum

722

5712

1.28

8.98

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

173

1054

1.65

8.94

1.4

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

226

1470

1.55

8.89

1.3

31.38

36.28

u/l

0.34

191

1263

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

311

2.23

8.89

2.7

1.8

557.81

26956.45

u/ml

0.88

(3025468) Yersinia sp identified in Specimen by Organism specific culture

172

1049

1.65

8.86

1.4

1.5

—

(44813793) Dust mix specific IgE antibody measurement

478

1.98

8.84

1.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

513

1.94

8.82

1.2

1.3

746.25

344.55

titre

—

(21494815) CD4 cells/100 lymphocytes in Specimen

127

713

1.79

8.81

1.7

2.2

39.71

37.32

1.00

118

702

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

331

2331

1.43

8.81

1.9

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

113

612

1.86

8.81

1.1

1.0

0.46

0.22

u/ml

0.73

176

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

493

1.96

8.78

1.2

1.3

62.00

62.05

titre

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

113

3.10

8.76

1.9

14.30

17.91

umol/l

1.28

113

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

102

537

1.91

8.68

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

104

552

1.89

8.64

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

176

1087

1.63

8.63

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

277

2.28

8.62

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

139

807

1.73

8.61

2.2

2.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

342

2.14

8.57

1.6

1.7

3.16

11.99

nmol/l

0.67

285

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

165

1006

1.65

8.52

1.2

1.3

—

nmol/l

—

(3002385) Erythrocyte distribution width [Ratio]

6782

70684

0.88

8.46

32.5

17.2

15.73

15.10

13.77

6681

69430

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

282

1953

1.46

8.23

1.3

6.87

7.51

u/ml

0.11

309

(3000475) Leukocytes [#/volume] in Synovial fluid

307

2162

1.43

8.20

1.6

12232.44

13521.66

e6/l

0.23

234

1564

(3014148) Varicella zoster virus Ab [Titer] in Serum

142

842

1.70

8.17

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

299

2100

1.44

8.11

1.3

64.98

34.17

u/ml

—

121

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

216

2.41

8.11

1.3

1.4

28.67

25.29

0.31

179

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

278

1926

1.46

8.11

1.3

9.85

4.21

u/ml

0.79

197

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

119

674

1.77

8.06

1.2

218.00

159.58

titre

0.29

118

(3017315) Amylase [Enzymatic activity/volume] in Urine

460

1.94

8.03

1.5

1.2

197.69

449.37

u/l

2.15

423

(3004451) EKG impression Narrative

420

1.98

7.96

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

660

8240

0.79

7.95

2.6

2.2

12.39

12.90

nmol/l

0.89

563

7373

(3009871) Measles virus Ab [Titer] in Serum

268

2.25

7.95

1.4

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

288

2.19

7.89

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

183

2.52

7.87

2.5

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

136

806

1.70

7.86

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

170

1067

1.60

7.85

1.4

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4224

39319

1.13

7.84

3.2

2.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

180

1146

1.58

7.83

1.2

1.3

0.60

2.88

nmol/l

0.99

169

1104

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

180

1150

1.58

7.72

1.2

1.3

0.15

0.27

nmol/l

1.26

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

169

1064

1.60

7.72

1.4

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.32

7.67

8.8

7.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

594

4682

1.29

7.64

3.7

2.8

0.36

0.30

e6/l

0.47

583

4589

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

527

1.85

7.55

1.3

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

109

615

1.78

7.51

1.5

2.1

74.97

71.93

1.90

104

579

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

149

918

1.63

7.45

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.60

7.28

1.0

1.3

61.47

42.50

mg/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

324

2361

1.38

7.17

2.9

3.1

1.78

1.59

mg/l

2.47

289

2155

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

249

2.22

7.10

1.2

1.3

176.65

463.08

ug/l

0.96

121

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

258

1812

1.43

7.06

2.2

1.7

0.93

0.81

nmol/l

1.52

195

1509

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

386

2904

1.34

6.98

2.1

3.4

34.14

48.08

mg/l

1.86

308

2343

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

162

1036

1.57

6.97

1.2

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

306

2.07

6.82

1.8

1.5

2.05

2.04

umol/l

0.04

290

(3035320) C reactive protein [Mass/volume] in Body fluid

561

1.77

6.77

3.4

2.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

384

2903

1.34

6.74

2.1

3.4

52.29

75.68

mg/l

0.61

302

2342

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

439

1.87

6.73

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

423

5461

0.76

6.68

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

111

2.80

6.56

1.0

1.1

—

(3025941) Bacteria identified in Stool by Culture

537

4268

1.27

6.50

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

384

2922

1.33

6.46

3.1

3.3

0.33

0.34

g/l

0.11

190

1340

(3016650) Hepatitis A virus Ab [Presence] in Serum

195

1323

1.48

6.42

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

425

1.87

6.41

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

425

1.87

6.41

1.3

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

2387

21663

1.13

6.40

4.9

3.9

0.00

estimate

3.18

888

6974

(3015736) pH of Urine

3443

31935

1.12

6.40

4.0

3.3

5.80

5.78

0.13

115

2243

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

328

1.99

6.37

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

153

988

1.56

6.35

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

268

2.10

6.33

1.3

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2103

18956

1.14

6.26

4.0

3.5

—

(3002619) Bacteria identified in Specimen by Culture

161

2.43

6.25

1.2

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

250

2.13

6.23

1.2

1.6

13.94

12.50

g/l

0.63

188

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

359

1.93

6.21

2.3

2.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

135

852

1.59

6.20

1.2

1.1

1.24

1.84

iu/ml

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

371

2828

1.32

6.18

2.0

3.3

29.82

3.55

ratio

0.47

224

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

198

1359

1.47

6.17

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

326

2440

1.35

6.15

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

146

941

1.56

6.13

1.1

1.2

57.94

64.76

u/l

0.54

130

837

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

383

2937

1.32

6.12

1.1

56.18

8.12

u/ml

—

(4035726) Immunohistochemistry procedure

900

7609

1.20

6.11

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

135

855

1.59

6.11

2.9

3.0

88.44

46.71

mg/l

0.46

621

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1424

12510

1.16

6.11

1.3

24.10

12.98

u/ml

1.85

452

4794

(3003694) ABO and Rh group [Type] in Blood

2019

22347

0.88

6.09

1.4

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.59

6.02

1.3

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

120

743

1.62

5.97

1.7

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

4280

40279

1.11

5.95

4.5

3.6

0.00

estimate

0.45

876

7085

(3032057) Clostridioides difficile [Presence] in Stool

184

2.29

5.92

1.8

1.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

525

1.74

5.91

2.3

2.8

39.84

36.80

0.91

288

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

129

817

1.59

5.86

1.6

1.3

1.53

1.43

nmol/l

0.43

121

732

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

227

1616

1.41

5.84

1.3

1.2

2.89

3.99

u/ml

0.26

118

(3044941) Cell count panel - Synovial fluid

194

1345

1.45

5.77

1.6

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

196

1363

1.45

5.74

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.46

5.72

1.3

1.0

—

(3033799) Differential panel - Peritoneal fluid

321

1.94

5.69

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

825

0.46

5.69

1.3

1.4

162.08

177.28

pmol/l

0.22

825

(3021601) Nitrite [Presence] in Urine by Test strip

4224

39796

1.11

5.65

5.9

4.7

0.00

estimate

0.80

942

7378

(3023511) Choriogonadotropin [Units/volume] in Urine

423

1.80

5.59

1.5

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

4226

39848

1.10

5.52

4.5

3.5

0.00

estimate

3.39

968

7793

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

153

2.36

5.46

1.2

1.0

5.45

9.12

u/ml

0.68

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.77

5.45

1.2

—

mmol/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

135

2.45

5.43

1.2

1.3

0.46

1.52

mmol/l

1.41

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

106

2.65

5.39

1.1

—

(3034426) Prothrombin time (PT)

279

1.98

5.38

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

105

647

1.63

5.37

1.0

1.1

304.30

283.39

mg/l

2.05

576

(3041918) Cholesterol [Moles/volume] in Pleural fluid

173

2.26

5.37

1.2

1.76

1.65

mmol/l

0.26

106

(3050794) Legionella sp Ab [Presence] in Serum

3.02

5.36

1.3

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

253

2.02

5.31

2.0

3.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

131

2.45

5.27

1.1

1.3

193.42

656.29

ng/l

0.39

(3027923) C peptide [Moles/volume] in Serum or Plasma

506

1.71

5.25

1.4

1.3

1.33

1.17

nmol/l

0.56

392

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.71

5.25

3.2

3.3

1.34

1.27

mg/l

0.08

(3033923) Metanephrine [Moles/time] in 24 hour Urine

156

2.31

5.24

1.1

0.71

0.72

umol/24h

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

418

1.78

5.21

3.0

3.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

463

1.73

5.19

2.3

2.1

45.56

155.07

ug/min

1.32

121

(4094501) Cardiovascular stress test using bicycle ergometer

188

2624

0.71

5.09

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

171

2.23

5.08

1.8

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

233

1711

1.37

5.04

1.9

1.7

43.73

4.39

iu/l

0.49

566

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

111

705

1.58

5.04

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

253

1887

1.35

4.97

1.4

9.67

9.52

u/l

0.07

192

1520

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

198

2726

0.72

4.94

1.8

1.7

9.63

3.80

mg/l

3.72

170

2013

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

411

1.76

4.92

1.8

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

3.66

4.92

1.3

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.66

4.90

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

419

1.75

4.90

1.2

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

169

2.19

4.79

1.5

1.6

0.32

0.40

ug/l

0.62

109

(3035947) Staphylolysin Ab [Units/volume] in Serum

415

1.74

4.77

1.3

1.1

4.14

4.09

iu/ml

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

101

637

1.59

4.75

1.7

—

(3017509) Phencyclidine [Presence] in Urine

3.16

4.75

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

206

1499

1.38

4.74

1.3

1.2

43.27

43.97

u/ml

0.02

155

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

219

2944

0.74

4.71

1.9

1.7

39.36

42.29

nmol/l

1.10

208

2838

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

120

2.42

4.70

1.2

1.3

36.78

345.90

u/l

0.68

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

114

743

1.54

4.66

1.3

24.86

32.04

u/l

1.51

588

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

330

1.82

4.66

1.0

1.1

100.59

98.21

0.30

263

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.90

4.59

3.2

2.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

605

1.59

4.55

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

108

700

1.55

4.54

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

141

2.27

4.53

11.3

11.5

4.79

5.67

mmol/l

1.42

141

(3023487) Leukocytes [#/volume] in Peritoneal fluid

363

1.77

4.50

1.9

2.3

638.63

3137.21

e6/l

0.64

261

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

100

640

1.57

4.45

1.2

—

71.00

—

(3045424) Erythrocytes [Presence] in Urine

196

1432

1.38

4.43

1.6

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

100

643

1.56

4.37

1.2

24.00

42.84

u/ml

—

(3022145) Colonoscopy Study observation

1106

9778

1.15

4.34

1.3

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

252

1.91

4.32

1.3

0.35

0.30

g/l

2.27

200

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

101

2.48

4.28

1.2

1.3

6.21

302280.85

nmol/l

0.72

(3020911) Cortisol [Moles/time] in 24 hour Urine

246

1.91

4.28

1.5

1.4

64.77

260.49

nmol/24h

1.72

246

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

516

1.61

4.19

1.1

1.3

40.38

22.85

u/l

1.07

435

(3044927) Protein electrophoresis panel - Urine

129

885

1.46

4.17

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

221

1.95

4.13

1.5

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

441

1.66

4.13

1.1

1.2

1.08

1.06

ratio

0.42

151

(3023420) DNA double strand Ab [Units/volume] in Serum

118

797

1.49

4.13

1.3

1.4

24.50

21.54

iu/ml

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

118

799

1.48

4.08

2.4

2.3

—

(4146454) Self-monitoring of blood glucose

141

989

1.43

4.07

2.6

2.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

182

1335

1.37

4.05

1.1

111.76

8214.27

iu/ml

0.54

290

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

414

1.67

4.02

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1205

10773

1.13

4.00

4.7

31.85

31.97

0.14

859

7425

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

156

2.12

3.98

1.3

1.2

0.79

70.31

mg/l

1.00

118

(3007463) Buprenorphine [Presence] in Urine

6.43

3.98

9.7

6.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

300

2370

1.27

3.96

2.3

152.68

117.12

ug/min

0.49

180

1444

(3035285) Chloride [Moles/volume] in Venous blood

144

1023

1.41

3.89

3.9

2.2

104.44

105.66

mmol/l

1.77

144

1012

(3041354) Potassium [Moles/volume] in Venous blood

144

1023

1.41

3.89

3.9

2.2

4.10

4.09

mmol/l

0.13

144

1012

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

495

4138

1.21

3.89

1.6

1.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

178

2.03

3.87

1.2

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

236

1814

1.31

3.86

4.9

3.0

1.60

1.64

mmol/l

0.36

229

1762

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

536

1.57

3.84

1.1

1.3

113.36

91.13

u/l

0.83

461

(3021788) Differential panel - Synovial fluid

212

1608

1.33

3.81

1.5

—

(3014891) Appearance of Pleural fluid

2.42

3.79

1.4

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

236

1819

1.30

3.79

1.6

1.7

380.51

286.91

mu/l

2.29

213

1674

(3036005) Urine sediment comments by Light microscopy Narrative

8.76

3.77

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

563

1.55

3.75

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

273

1.80

3.72

3.1

3.3

57.61

53.72

0.67

262

(3033705) Calcium.ionized [Moles/volume] in Venous blood

141

1008

1.40

3.70

4.0

2.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

421

0.40

3.70

1.2

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

403

3320

1.22

3.69

2.6

3.7

3839.89

1726.63

u/ml

0.45

335

2874

(40760888) Immunoglobulin light chains.free panel - Serum

281

2226

1.27

3.66

1.9

3.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

334

1.71

3.65

1.5

1.4

50.86

65.99

2.63

278

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

322

1.71

3.55

1.9

2.1

6706.76

12567.55

e6/l

0.41

187

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

206

1.90

3.51

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

206

1.90

3.51

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

206

1.90

3.51

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

206

1.90

3.51

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

541

4607

1.18

3.50

1.7

1.8

—

(40768441) Liver Pathology biopsy report

631

1.49

3.46

1.3

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

236

1.83

3.45

1.4

1.5

9.47

9.33

ug/l

0.06

236

(3038515) Glucose [Moles/volume] in Venous blood

221

1716

1.29

3.40

5.1

3.1

7.72

7.71

mmol/l

0.02

216

1675

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

350

1.66

3.37

3.6

2.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

409

1.59

3.22

1.4

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

355

1.64

3.21

1.1

84.00

13.45

u/ml

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

529

1.52

3.19

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

410

1.59

3.19

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

530

1.51

3.16

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.31

3.16

1.0

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

388

1.60

3.15

2.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

229

1.79

3.14

1.4

26.34

30.06

g/l

0.24

174

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.36

3.14

1.3

1.2

12.15

9.44

mg/l

0.32

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.43

3.10

1.0

1.1

5467.60

3013.81

ng/l

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.33

3.07

1.6

2.6

1.24

1.00

mmol/l

0.17

(3022621) pH of Urine by Test strip

614

5343

1.16

3.07

3.9

2.8

—

(3020491) Glucose [Moles/volume] in Blood

584

1.48

3.04

2.1

1.7

7.64

6.94

mmol/l

0.90

392

(3049717) Cytology report of Urine Cyto stain

450

3825

1.18

3.02

2.8

—

(3000012) Reticulocyte production index

172

1315

1.31

3.01

1.7

2.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

168

1.91

2.98

1.5

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6199

60303

1.07

2.95

4.2

3.7

15.03

14.82

pmol/l

7.92

5560

54552

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.83

2.91

1.8

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

512

0.53

2.91

1.6

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.09

2.88

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

109

2.11

2.83

1.2

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

109

2.11

2.83

1.2

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

109

2.11

2.83

1.2

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

283

1.66

2.81

1.6

1.4

6.75

2.41

1.34

242

(3002256) Pathology report gross observation

1011

11156

0.90

2.80

1.3

—

(3017704) Immunofixation for Urine

491

1.49

2.74

1.3

1.5

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

132

1.97

2.69

1.5

10.25

9.92

0.02

(3016244) Insulin [Units/volume] in Serum or Plasma

374

1.55

2.65

3.7

3.3

26.94

26.10

mu/l

0.06

354

(3043238) Trisomy 21 risk [Likelihood] in Fetus

404

0.49

2.65

1.6

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

109

797

1.37

2.62

1.5

1.2

—

(3045414) Leukocytes [Presence] in Urine

441

3794

1.17

2.60

2.1

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

133

1004

1.33

2.60

2.1

4950.46

3366.60

u/l

0.20

383

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.25

2.60

1.2

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

457

1.49

2.58

1.1

21.17

31.19

u/l

1.18

412

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1197

10974

1.10

2.58

1.5

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

401

1.52

2.57

6.8

11.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7304

74437

0.93

2.56

5.4

4.4

1.82

2.18

mu/l

5.23

6593

67789

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

458

1.49

2.56

1.1

89.74

91.50

u/l

0.07

417

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

557

1.44

2.55

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

557

1.44

2.55

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

557

1.44

2.55

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

116

861

1.35

2.54

1.3

110985.04

117432.07

e6/l

0.04

597

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

172

2176

0.79

2.53

2.2

1.8

195.78

199.60

pmol/l

0.16

160

2045

(3047352) Trisomy 18 risk [Likelihood] in Fetus

396

0.50

2.51

1.5

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

431

3716

1.17

2.49

1.6

—

(3005033) Fetal Nuchal fold Thickness US

393

0.51

2.46

1.6

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

553

1.43

2.46

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

553

1.43

2.46

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

189

1508

1.26

2.45

4.2

3.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

290

2421

1.20

2.44

1.6

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

554

1.43

2.44

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

280

1.61

2.41

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

288

1.60

2.41

2.3

2.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

481

1.46

2.41

2.0

1.8

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.00

2.40

1.8

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

147

1140

1.29

2.40

1.4

1.6

57.58

59.13

0.18

100

713

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.11

2.38

1.1

—

(40768443) Skin Pathology biopsy report

435

3771

1.16

2.36

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

105

782

1.35

2.29

1.1

—

84.33

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

392

3382

1.17

2.28

1.3

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

148

1.83

2.27

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

113

1.95

2.24

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

260

3104

0.83

2.24

2.3

3.8

49.13

57.19

u/ml

0.30

246

2982

(3023323) Follitropin [Units/volume] in Serum or Plasma

250

2078

1.21

2.24

1.4

1.3

29.48

33.55

iu/l

1.28

207

1765

(3024869) Neuronal Ab [Presence] in Serum

179

1.73

2.21

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

392

1.48

2.19

1.6

10.17

9.39

ug/l

0.11

354

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

478

0.58

2.18

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

477

0.59

2.16

1.6

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

577

1.39

2.15

1.6

1.5

4.35

7.31

u/l

2.08

465

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

476

0.59

2.15

1.6

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

196

1.69

2.14

1.3

1.2

497.55

279.64

pmol/l

0.41

151

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

475

0.59

2.13

1.6

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

327

2798

1.17

2.13

1.7

1.6

—

(3044889) 12 lead EKG panel

5903

60418

0.94

2.13

5.1

3.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

499

0.60

2.12

4.3

6.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.20

2.09

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

198

1621

1.23

2.08

1.5

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

210

1730

1.22

2.08

5.7

3.4

29.63

29.09

mg/l

0.07

137

1084

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

229

1.62

2.07

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

176

1.71

2.05

1.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

254

1.58

2.02

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.22

2.00

1.3

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

2.63

2.00

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.00

12.9

7.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.81

2.00

1.0

—

(3019150) Specific gravity of Urine by Refractometry

1850

17472

1.07

1.98

5.1

4.0

1.02

kg/l

0.42

300

2560

(3047007) Chlamydophila sp Ab [Presence] in Serum

128

1004

1.28

1.97

1.3

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

126

1.83

1.97

1.8

1.7

42.09

47.10

pmol/l

0.19

107

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

112

1.88

1.95

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

130

1025

1.27

1.93

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.96

1.93

1.0

1.3

—

mmol/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.73

1.93

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

314

1.50

1.92

2.8

2.9

27.88

28.40

umol/l

0.13

234

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

113

1.86

1.91

2.7

3.8

35.56

40.26

umol/l

0.46

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

239

2015

1.19

1.89

1.3

544.55

576.14

mg/l

0.36

221

1911

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

158

1.71

1.88

1.1

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.18

1.88

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

440

1.41

1.87

1.5

1.6

12.32

12.19

umol/l

0.01

305

(3039162) Centromere protein B Ab [Units/volume] in Serum

119

935

1.28

1.84

1.3

72.99

55.92

u/ml

—

(3016135) IgD [Mass/volume] in Serum

4.17

1.82

1.6

1.0

137.18

36.14

mg/l

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

3.05

1.79

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

176

1.65

1.78

1.1

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

386

1.43

1.78

4.4

6.2

66.37

1684.06

mg/l

1.09

285

(40768793) Breast Pathology biopsy report

110

1397

0.79

1.77

1.4

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.17

1.77

1.2

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

600

1.34

1.75

1.5

2.0

17.53

17.13

nmol/l

0.14

566

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.33

1.74

1.5

1.0

3.00

2.11

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

568

0.67

1.73

1.1

1.3

1.57

1.55

g/l

0.17

568

(3023410) Appearance of Cerebral spinal fluid

768

1.29

1.71

1.9

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

194

1.60

1.71

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

210

1.57

1.70

1.1

92.44

85.06

0.52

108

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

791

7270

1.10

1.69

3.6

2.6

64.08

65.51

ml/min/173m2

0.38

350

2825

(3029634) Reagin Ab [Titer] in Serum by VDRL

132

1063

1.24

1.68

2.6

2.4

12.33

2.77

titre

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

317

1.45

1.65

1.2

2.1

188.00

160.77

1.17

297

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

239

2044

1.17

1.64

1.5

1.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.03

1.64

1.1

1.0

53.71

8.19

iu/ml

—

(3013293) Extractable nuclear Ab [Presence] in Serum

112

1.79

1.64

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

712

1.29

1.63

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

616

1.32

1.63

1.4

1.3

2.14

2.12

mmol/l

0.08

580

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.14

1.61

1.3

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

1.87

1.60

1.2

1.3

—

110.27

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

2.50

1.59

7.8

5.7

398.00

436.69

umol/l

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.50

1.59

1.4

48.45

15.44

nmol/l

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

412

1.39

1.59

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

847

0.74

1.59

1.6

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

271

1.48

1.58

4.7

8.1

—

(40761535) Cells panel - Urine sediment

773

7128

1.09

1.56

3.6

3.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

207

1.55

1.56

1.1

1.2

89.06

85.64

0.15

110

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.11

1.54

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

231

1983

1.17

1.54

1.4

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

161

1.62

1.52

1.1

0.28

1.35

u/ml

0.93

(40758292) HTLV I+II Ab panel - Serum

142

0.42

1.51

1.0

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

193

1.56

1.50

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

209

1.53

1.50

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

154

1.62

1.49

1.1

1.3

79.33

75.02

—

(3002079) Sodium [Moles/time] in 24 hour Urine

367

1.39

1.48

1.2

154.98

175.33

mmol/24h

0.95

367

(3016750) Collection duration of Urine

556

1.32

1.48

2.2

488.56

492.79

min

0.14

415

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.43

1.47

1.0

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

208

1778

1.17

1.47

1.3

4.02

3.85

mmol/l

1.08

187

1674

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

687

0.73

1.47

1.0

43.54

43.26

ng/l

0.02

469

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

496

1.33

1.47

1.4

1.5

5.56

6.13

u/l

0.71

429

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.81

1.47

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

235

1.49

1.46

2.0

2.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

684

0.73

1.44

1.0

832.03

726.36

ng/l

1.06

461

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.92

1.43

1.0

1.5

5.77

19.87

pmol/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.31

1.42

1.3

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

204

1.52

1.42

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

682

0.73

1.41

1.0

335.03

333.16

ng/l

0.01

475

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

141

1.63

1.41

1.8

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

213

1.50

1.40

1.2

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.25

1.40

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

197

1.52

1.39

2.1

2.3

7.49

7.97

mmol/l

0.24

113

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.08

1.38

1.5

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.94

1.38

1.2

1.1

4.77

13.31

u/l

1.26

(3006462) Nitrate [Presence] in Urine

399

1.36

3.3

3.4

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.94

1.36

1.0

0.03

0.15

u/ml

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2213

21259

1.05

1.35

4.4

3.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

232

1.47

1.33

1.4

1.3

33.07

37.77

0.36

149

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

206

1777

1.16

1.33

1.5

1.4

14.04

28.43

e6/l

1.16

161

1359

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

206

1778

1.16

1.32

1.6

1.4

1615.93

1516.96

e6/l

0.05

168

1436

(3016018) Differential panel - Cerebral spinal fluid

106

861

1.23

1.32

1.6

1.4

—

(3045142) Bone marrow Pathology biopsy report

1064

0.80

1.30

1.3

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

446

1.32

1.29

1.4

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

234

1.45

1.28

4.8

8.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.76

1.28

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

153

1.57

1.28

1.1

1.2

105.56

79.40

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

2.29

1.26

7.8

5.3

18.69

16.48

mmol/l

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

536

1.29

1.26

1.2

1.1

390.34

297.52

mg/l

0.38

465

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.82

1.25

1.1

1.2

95.16

119.94

ug/l

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.40

1.24

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.97

1.22

1.2

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.16

1.21

1.4

1.6

—

(3024263) Appearance of Synovial fluid

487

1.30

1.20

1.4

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

213

0.56

1.19

1.0

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

557

0.74

1.18

1.8

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

214

1.45

1.17

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.70

1.17

2.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.50

1.15

1.0

2.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

412

1.31

1.14

1.1

8.43

11.25

iu/ml

—

103

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

199

1.46

1.14

1.2

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8161

82347

0.95

1.13

29.9

14.4

26.29

25.31

mg/l

2.03

7497

65507

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

154

0.52

1.13

1.6

3.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

931

8774

1.07

1.13

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

3263

33519

0.96

1.13

2.2

2.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.33

1.12

1.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.90

1.12

2.3

3.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

127

1072

1.19

1.11

2.1

2.5

1.47

1.31

g/24h

0.23

539

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.96

1.11

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

250

2224

1.13

1.09

2.9

2.5

—

(4034850) Laboratory test

248

2783

0.89

1.08

17.9

9.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

501

0.74

1.06

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

186

1627

1.15

1.05

1.2

1.3

143.18

212.42

miu/ml

1.44

670

(3013762) Body weight Measured

2.12

1.05

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

148

1713

0.86

1.03

1.3

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.27

1.03

1.0

2.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.06

1.02

1.0

1.1

1.34

0.28

u/ml

—

(3048879) Bone marrow aspiration report

255

1.37

1.02

1.2

2.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

115

1.57

0.99

1.6

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.84

0.98

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.17

0.98

1.2

303.40

620.86

nmol/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

370

1.30

0.98

2.8

2.2

47.13

53.43

umol/l

0.72

309

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.67

0.97

1.1

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.63

0.97

2.2

2.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

558

1.24

0.96

1.3

1.2

70.78

43.86

mg/l

0.40

468

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

117

0.51

0.93

1.2

1.1

115.37

62.61

u/ml

—

112

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.22

0.93

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.72

0.92

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

427

1.27

0.92

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

427

1.27

0.92

1.3

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

472

1.25

0.91

1.8

2.40

3.01

u/field

0.24

333

(3015183) Erythrocyte sedimentation rate

350

0.71

0.91

1.4

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

348

1.29

0.91

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

676

0.80

0.90

2.9

5.3

273.54

60.80

u/ml

0.45

204

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

102

1.57

0.90

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

279

1.33

0.89

1.3

1.2

39.90

39.87

g/l

0.00

148

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

129

0.54

0.87

4.9

9.1

0.23

0.32

umol/l

—

123

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.61

0.87

2.5

2.2

57.50

57.83

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

193

0.62

0.87

1.7

4.8

47.67

59.17

u/l

0.31

186

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

382

3525

1.09

0.87

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.82

0.85

10.3

9.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

398

1.26

0.83

1.3

39.60

62.65

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.74

0.82

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

197

1.37

0.81

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

524

5588

0.93

0.81

2.4

25.23

23.19

au/ml

0.14

389

(3022689) Creatine [Moles/volume] in Urine

284

1.30

0.81

1.7

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

232

1.34

0.80

1.2

110.61

139.48

nmol/l

0.49

171

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

215

1940

1.11

0.80

1.1

15.88

7.76

u/ml

0.27

233

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

484

4527

1.07

0.80

2.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

482

1.23

0.79

1.0

1.1

8.63

8.74

nmol/l

0.01

111

(3009015) Lactate [Moles/volume] in Synovial fluid

106

1.51

0.78

1.1

1.3

5.29

6.62

mmol/l

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.67

0.78

1.2

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.62

0.78

1.0

0.03

1.35

u/ml

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.52

0.78

5.6

5.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.51

0.77

2.8

2.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

210

1899

1.11

0.76

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.76

0.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

853

1.16

0.75

1.3

1.5

26.65

28.54

0.20

529

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.08

0.74

1.2

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

227

1.32

0.74

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

505

1.21

0.73

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

800

1.16

0.73

2.5

2.3

642.24

679.03

0.33

541

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.61

0.72

1.6

1.4

516.11

326.23

umol/24h

—

(3008898) HLA-B27 [Presence]

204

2248

0.91

0.72

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

138

1554

0.89

0.72

1.7

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.55

0.71

1.1

0.29

0.26

u/ml

0.03

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.92

0.70

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

574

1.19

0.68

1.4

15.47

13.26

umol/l

1.08

542

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.64

0.68

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

357

3331

1.07

0.67

1.1

300.45

247.02

titre

0.17

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

188

1.33

0.66

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1054

0.87

0.64

1.4

1.2

7.52

7.57

mmol/l

0.06

923

(3034891) Synovial lining cells/100 cells in Synovial fluid

440

1.21

0.64

1.3

1.5

3.00

3.35

—

105

(40768446) Kidney Pathology biopsy report

377

1.22

0.63

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

181

1.33

0.63

1.3

79.48

69.41

mu/l

0.11

137

(3025018) Bordetella pertussis Ab [Titer] in Serum

378

1.22

0.62

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

102

0.59

0.62

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

147

1.36

0.61

4.8

5.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.60

0.61

3.5

3.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

110

975

1.13

0.60

1.7

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

411

0.80

0.59

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.54

0.59

1.1

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.51

0.58

3.0

5.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.71

0.57

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.48

0.57

1.3

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.67

0.56

1.2

1.1

189.00

263.29

nmol/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.58

0.56

1.2

1.0

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.45

0.56

1.1

1.6

5.63

13.15

—

(40763590) HLA-DQ beta [Type]

1.62

0.55

1.0

—

(40760409) HLA-A [Type] by High resolution

1.62

0.55

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.62

0.55

1.0

—

(40760410) HLA-B [Type] by High resolution

1.62

0.55

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

211

1949

1.08

0.54

3.0

3.6

120.66

732.15

u/ml

3.06

183

1798

(40762814) Titanium [Mass/volume] in Blood

168

1.31

0.54

2.6

2.3

3.66

3.87

ug/l

—

(3013862) HLA-DP [Type]

1.58

0.54

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.58

0.54

1.3

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

186

1.29

0.54

4.5

7.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.54

0.53

3.0

14.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1045

0.89

0.52

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

223

1.26

0.52

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

126

1.35

0.51

1.2

1.4

42.40

55.27

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.47

0.50

3.0

5.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

280

0.79

0.49

1.2

1.6

2.97

4.32

ug/l

0.42

207

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

261

1.23

0.49

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

465

0.84

0.49

1.2

1.8

—

(40765096) Chromosome analysis panel by Banding

290

0.79

0.48

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

108

0.65

0.48

1.3

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

155

0.71

0.48

6.1

6.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.40

0.48

1.1

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

200

0.75

0.47

6.6

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

111

1.35

0.46

1.5

—

(3025130) Human papilloma virus identified in Specimen

664

1.13

0.46

1.8

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.38

0.45

1.3

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.62

0.45

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1044

0.90

0.45

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

103

1.36

0.45

1.1

1.3

28.66

30.73

nmol/l

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

487

5086

0.96

0.44

1.3

37.31

55.33

au/ml

1.74

289

(3029396) Erythrocyte agglutination [Presence] in Blood

1.45

0.44

2.5

—

(4281824) Cell count and differential, peritoneal fluid

820

0.89

0.43

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

602

1.13

0.43

1.7

1.6

—

(3027874) Urate [Moles/volume] in Urine

1.61

0.43

1.2

1.1

1.49

1.74

mmol/l

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

185

0.76

0.43

1.8

2.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

340

1.18

0.43

1.5

2.0

—

(3012565) Volume of 24 hour Urine

462

1.15

0.42

2.0

2.3

2032.43

1924.67

0.15

403

(3020650) Glucose [Presence] in Urine

203

1.23

0.42

1.3

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

397

1.16

0.41

1.2

1.1

0.98

1.08

u/l

2.04

192

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.41

0.0

3.1

—

1.58

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

314

1.18

0.41

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

114

1.32

0.40

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

324

1.17

0.40

1.1

1436.50

1529.58

miu/ml

0.24

324

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.34

0.39

1.2

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.43

0.39

1.4

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3123

30831

1.02

0.38

4.9

3.7

—

(3006270) Folate [Moles/volume] in Blood

693

0.89

0.36

1.2

369.78

364.67

nmol/l

0.07

576

(3013166) Neutrophils/100 leukocytes in Synovial fluid

281

1.17

0.36

1.3

59.80

54.56

0.33

237

(3028679) Herpes simplex virus Ab [Presence] in Serum

347

1.15

0.35

1.3

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

126

1.27

0.35

1.1

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

218

1.19

0.34

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

154

1.23

0.33

1.4

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

208

2197

0.95

0.33

5.4

3.8

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

1.30

0.33

1.2

1.5

2.00

1.04

—

(4212803) Bone marrow aspirate examination

0.67

0.32

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.67

0.32

1.2

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

392

0.87

0.32

1.2

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

137

1.24

0.32

1.1

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.30

0.31

1.3

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.35

0.31

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

358

0.87

0.31

1.0

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

138

1.23

0.30

3.9

5.2

32.45

54.87

ug/min

1.50

113

(3001729) Color of Synovial fluid

1.33

0.30

1.2

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.25

0.29

1.6

1.1

—

(3016228) CD19 cells/100 cells in Blood

354

1.13

0.29

1.6

2.0

7.53

8.28

0.23

340

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.23

0.29

1.7

1.35

1.39

umol/l

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

288

1.15

0.28

1.7

1.9

—

(1002224) Polysomnography panel

324

3367

0.96

0.28

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.29

0.28

1.1

1.6

52.13

32.61

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

948

0.93

0.27

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

150

0.80

0.27

1.5

1.6

4.30

2.15

ug/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.21

0.26

1.3

1.5

—

(3000285) Sodium [Moles/volume] in Blood

113

1.24

0.26

1.3

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.30

0.26

1.1

1.2

1.96

1.80

umol/24h

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

377

1.11

0.25

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

179

1.17

0.25

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

170

1619

1.05

0.24

1.7

1.8

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.73

0.24

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

307

0.88

0.23

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

210

2015

1.04

0.23

1.7

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

332

1.11

0.23

1.1

1.0

1.12

0.88

u/ml

0.14

103

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

211

0.85

0.23

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

116

1.21

0.22

1.4

1.3

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.5

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

152

1452

1.05

0.21

1.9

4.20

5.16

mmol/24h

2.90

131

1280

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

440

1.09

0.21

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.16

0.21

1.4

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

469

1.09

0.21

9.2

5.9

103.79

541.09

u/ml

0.67

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.21

0.0

2.0

—

16.69

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1110

10935

1.02

0.20

9.9

7.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

166

0.84

0.20

1.0

1.3

—

(40768795) Lymph node Pathology biopsy report

880

0.94

0.19

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.75

0.17

2.4

2.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.74

0.17

1.8

5.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

186

1.13

0.16

1.1

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

514

1.07

0.16

1.5

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.11

0.16

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.75

0.15

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2280

22969

0.99

0.15

1.7

1.59

1.38

mmol/l

16.16

1914

19116

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

507

1.07

0.15

1.4

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

1.19

0.14

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

694

0.95

0.13

1.3

1.4

0.20

0.23

nmol/l

0.39

500

(3005011) Chlamydia sp Ab [Titer] in Serum

106

0.85

0.13

1.6

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

240

1.08

0.11

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

270

0.93

0.10

1.3

1.2

44.67

21.78

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

119

1224

0.97

0.09

1.3

1.2

—

(21494434) Karyotype in Bone marrow

782

1.04

0.09

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

950

1.03

0.09

1.1

3.48

3.38

u/ml

0.04

419

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

223

1.08

0.09

1.2

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

451

4455

1.01

0.09

1.2

118.46

135.92

iu/ml

0.42

134

1663

(3045462) Protein/Creatinine [Ratio] in Urine

0.78

0.08

1.0

5.2

72.40

67.38

g/mol

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

273

1.06

0.08

1.1

1.0

0.34

1.58

u/ml

0.53

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

166

1.08

0.07

2.2

1.6

—

64.63

—

(3044009) aPTT.lupus sensitive (LA screen)

0.86

0.07

1.3

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.81

0.07

1.0

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.07

0.07

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.05

0.07

1.2

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

0.88

0.06

3.9

2.6

344.13

301.15

umol/l

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.84

0.06

1.4

1.3

—

501.98

—

(3000330) Specific gravity of Urine by Test strip

432

4281

1.01

0.06

4.3

3.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

335

1.04

0.06

1.2

1.1

111.82

432.88

ng/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

306

1.05

0.05

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

228

1.05

0.05

1.7

1.9

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

219

1.05

0.04

2.7

5.8

65.00

69.36

0.23

178

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

101

1.09

0.04

2.5

2.7

0.73

0.41

u/field

0.40

101

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

648

1.02

0.03

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

669

1.02

0.02

2.2

2.0

1.97

1.61

u/field

0.24

293

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

419

0.98

0.02

1.6

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

148

1492

0.99

0.02

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

258

0.97

0.02

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

238

2368

1.01

0.01

2.4

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

104

1.06

0.01

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

525

5242

1.00

0.00

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

286

1.01

0.00

1.1

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

315

1.02

0.00

1.1

1.0

6.92

0.55

u/ml

0.47

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

122

0.98

0.00

1.0

1.3

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.5

—

11.63

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.5

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

1.02

-0.00

1.8

1.4

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

273.40

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.52

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.00

-0.00

1.4

1.8

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.97

-0.00

1.0

2.2

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

19.33

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.95

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint COPD_EARLY and mortality.

Females

Parameter	HR [95% CI]	p-value
COPD_EARLY	5.788 [5.33, 6.28]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 5790 out of 19608 females with COPD_EARLY died.

Males

Parameter	HR [95% CI]	p-value
COPD_EARLY	4.076 [3.78, 4.4]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 14125 out of 35925 males with COPD_EARLY died.

Mortality risk

Mortality risk for people of age

years, who have COPD_EARLY.

N-year risk	Females	Males
1	0.467%	0.687%
5	2.872%	4.076%
10	6.558%	10.345%
15	12.484%	19.555%
20	21.139%	31.398%

Relationships between endpoints

↥

Index endpoint: COPD_EARLY – Early onset COPD

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Early onset COPD

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints